| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Aurora Cannabis Inc. Common Shares$2.62
-0.05 (-1.88%)
F 10Pipeline Score Tools & Services · Clinical
Market Cap
194.51 M
EPS
-1.15
P/E Ratio
-2.99 $
Value Trade
1.63 M
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
12.35 K
Monthly Burn
12.35 K
Runway
12,345 mo
Overview
Volume
661.23 K
52 Week Range
3.07 - 6.67
% held by Insiders
0.67 %
% held by Institutions
9.58 %
Enterprise Value
178.51 M
Total Shares
61.34 M
Short %
12.37 %
Float Shares
61.09 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Aurora Cannabis Inc. Common Shares
326Total events
2Upcoming
49Tier-1 (high impact)
2018 – 2026Coverage
Upcoming catalysts 2
TBD
T2Quarterly Update
Subscribe to view catalyst details
TBD
T2Quarterly Update
Subscribe to view catalyst details
Event history 2
TBD
●Quarterly UpdateCorporate
Subscribe to view catalyst details
TBD
◆Quarterly UpdateCorporate
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
F10
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 9%
Micro Cap (rank 831 of 912)
Percentile RankAurora Cannabis Inc. Common Shares has significant pipeline risk (10/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in ACB
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
ACB Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-ACB
Jul 9, 2026Aurora Named to TIME Canada's Best Companies 2026 List
Aurora Cannabis Inc. has been awarded a spot on TIME Canada's Best Companies 2026 list, marking a historic achievement as the first cannabis company to receive this recognition. The award highlights the company's strong performance in employee satisfaction, revenue growth, and sustainability. CEO Miguel Martin emphasized the importance of this recognition for the company's culture and commitment to advancing medical cannabis globally.
Read more →-ACB
Jul 8, 2026Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Aurora Cannabis Inc. has announced the availability of its management information circular for the upcoming annual general meeting of shareholders. The meeting is scheduled for August 7, 2026, and will be held virtually, allowing all shareholders to participate regardless of location. The company encourages early voting and provides resources for shareholders needing assistance.
Read more →-ACB
Jun 11, 2026▼ -6.4%on this news
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
Aurora Cannabis reported record annual revenue of $288.6 million for fiscal year 2026, marking an 18% year-over-year growth. The company also achieved an adjusted EBITDA of $53.8 million, a 32% increase from the previous year. Despite these successes, Aurora faced a net loss of $27.6 million in Q4 2026, attributed to increased expenses and strategic shifts away from the consumer cannabis market. The acquisition of Safari Flower Company is expected to bolster Aurora's capacity in profitable international markets.
Read more →-ACB
Jun 2, 2026Aurora Deepens its Impact for Veterans Across Canada
Aurora Cannabis Inc. is enhancing its support for Veterans in Canada through its Strains for Heroes program, which donates a portion of profits to Veteran-focused organizations. Recent contributions include support for food security, mental health initiatives, and community engagement. The company emphasizes its commitment to understanding and addressing the needs of Veterans.
Read more →-ACB
May 28, 2026▲ +5.8%on this newsshared move
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
Aurora Cannabis Inc. has announced a conference call scheduled for June 11, 2026, to discuss its fourth quarter and fiscal year 2026 financial results. The call will be hosted by CEO Miguel Martin and CFO Simona King, following the release of the financial statements. The company continues to emphasize its commitment to patient care and global expansion in the medical cannabis sector.
Read more →-ACB
May 21, 2026Burrard St, 3rd Floor Date
Aurora Cannabis Inc. has announced the details for its upcoming Annual Meeting of Security Holders. The meeting is scheduled for August 7, 2026, with a record date for notice and voting set for June 15, 2026. The meeting will be held virtually, and the issuer will not send proxy-related materials directly to non-objecting beneficial owners but will pay for delivery to objecting beneficial owners. Additional Notice and Access requirements are also outlined in the announcement.
Read more →-ACB
May 14, 2026Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
Aurora Cannabis Inc. has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars, Farm Gas™ and Driftwood Diesel™, developed at its research facility in Comox, British Columbia. This certification provides Aurora exclusive rights to grow and sell products from these varieties, enhancing its global competitive position. The rights recognize the company's significant investment in breeding and genetic development.
Read more →-ACB
Apr 28, 2026Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets NASDAQ | TSX: ACB Q1 launches reinforce Aurora's medical-first strategy, expanding access to high-quality produ
Aurora Cannabis Inc. has announced significant expansions in its global medical cannabis portfolio with new product launches targeting key international markets such as Canada, Europe, and Australia. The new products include dried flowers, pre-rolls, and pastilles, designed to meet local regulatory standards while enhancing patient choice. This initiative supports Aurora's medical-first strategy and reinforces its commitment to quality and reliability in supplying cannabis products to a growing market. The rollouts are scheduled between now and June 2026, showcasing the company's focus on innovation and consumer demand.
Read more →-ACB
Apr 15, 2026Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
Aurora Cannabis has acquired Safari Flower Company for $26.5 million, enhancing its EU GMP capacity. This acquisition is aimed at expanding its supply of high-quality cannabis to international markets, including Germany and Australia. The deal is expected to contribute positively to Aurora's financial performance starting in fiscal year 2027.
Read more →-ACB
Apr 15, 2026FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change April 14 , 2026 Ite
Aurora Cannabis Inc. announced the acquisition of 100% of the shares of Safari Flower Company through its subsidiary for a total consideration of $26.5 million. The deal includes a cash payment of $15 million and issuance of 2,417,180 common shares. This acquisition is expected to strengthen Aurora's position in the EU GMP certified cannabis market. Further information can be obtained from Nathalie Clark, the Executive Vice President and General Counsel.
Read more →-ACB
Mar 30, 2026Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
Aurora Cannabis Inc. has been recognized by The Globe and Mail for the second consecutive year in its Report on Business Women Lead Here list, highlighting the company's commitment to gender diversity at the executive level. With 50% female leadership, Aurora emphasizes a culture of respect and accountability, fostering an environment for female leaders to thrive. This recognition underscores the company's dedication to inclusive leadership and meaningful contributions to the cannabis industry.
Read more →-ACB
Feb 17, 2026Aurora to Participate in the TD Cowen 46th Annual Health Care Conference NASDAQ | TSX: ACB Canada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market Opportunities EDMONTON, AB
Aurora Cannabis Inc. (NASDAQ: ACB) will participate in the TD Cowen 46th Annual Health Care Conference on March 2, 2026, in Boston, MA. The CFO, Simona King, will discuss the company's growth strategy and market opportunities during a fireside chat and one-on-one meetings with investors. Aurora continues to focus on expanding its global footprint while enhancing its reputation as a leader in medical cannabis. The company also recently completed a transaction with Bevo Agtech Inc., indicating ongoing efforts for strategic growth.
Read more →-ACB
Feb 4, 2026▼ -7.6%on this news· ran to -18% by day 1
Execution Version
Aurora Cannabis Inc. has confirmed an agreement with TD Securities (USA) LLC for the issuance and sale of common shares valued up to US$100 million. This arrangement will enable the Company to issue shares during the agreement term, subject to certain conditions. The necessary regulatory approvals have been obtained, allowing the Company to proceed with this financial strategy as outlined in their filed prospectuses and registration statements.
Read more →-ACB
Feb 4, 2026▼ -7.6%on this news· ran to -18% by day 1
Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program NASDAQ | TSX
Aurora Cannabis has announced the filing of a prospectus supplement for a new at-the-market offering program, allowing the company to sell up to $100 million in common shares. The proceeds from this offering will be utilized for strategic purposes, including increasing cultivation capacity and pursuing mergers and acquisitions. The program aims to enhance investor opportunities and strengthen the company's financial position. Sales will be conducted through open market distributions on NASDAQ and other platforms, adhering to regulatory guidelines.
Read more →-ACB
Feb 4, 2026▼ -7.6%on this news· ran to -18% by day 1
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results NASDAQ | TSX: ACB Expands YoY Total Net Revenue 1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue 1 Increasing by 12% to a Record $76.2 million
Aurora Cannabis announced its third quarter results for fiscal 2026, showcasing a 7% increase in total net revenue to $94.2 million, largely driven by a record $76.2 million in global medical cannabis revenue. The company also reported a sequential rise in adjusted EBITDA to $18.5 million. Despite these advancements, Aurora faced a net loss from continuing operations of $1.7 million, marking a decline from the prior year's profits, largely due to a significant drop in consumer cannabis revenue. The company is shifting focus away from lower-margin consumer segments to concentrate on the higher-margin medical cannabis market.
Read more →-ACB
Feb 3, 2026Form 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2. Date of Material Change
Aurora Cannabis Inc. announced a significant change involving a definitive agreement with Bevo Agtech Inc. under which it will exchange its common shares for preferred shares in Bevo Agtech. This Bevo Transaction is pending certain conditions, including approval from Bevo Agtech shareholders. Upon closing, Aurora will receive dividends and a share of cashflow from Bevo Agtech, but will lose its rights to appoint directors at Bevo Agtech. Additionally, the financial results of Bevo Agtech will be presented as a discontinued operation in Aurora's statements.
Read more →-ACB
Jan 21, 2026Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has announced that it will host a conference call on February 4, 2026, to discuss its financial results for the third quarter of fiscal 2026. This call will be led by Executive Chairman Miguel Martin and Chief Financial Officer Simona King. The results will be shared before the markets open on the same day. This event indicates Aurora's ongoing efforts to keep investors informed about its performance and strategies in the competitive cannabis industry.
Read more →-ACB
Jan 14, 2026Aurora Achieves Significant Progress in Disease Resistance Research NASDAQ | TSX: ACB As a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cul
Aurora Cannabis has made significant progress in its research on powdery mildew-resistant cultivars, marking a critical step toward commercialization. The company's research, building on a breakthrough discovery of a genetic source of resistance, involves multiple breeding trials to ensure effective integration of the resistance trait. The transition to production trials at the Aurora Ridge facility aims to validate these scientific advancements. With plans to commercialize these cultivars later this year, Aurora is positioning itself as a leader in innovative cannabis cultivation techniques.
Read more →-ACB
Nov 5, 2025Aurora Cannabis Announces Fiscal 2026 Second Quarter Results Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net Revenue 1 by 22% to Record $42.7
Aurora Cannabis announced its financial results for the second quarter of fiscal 2026, showing a record net revenue of $70.5 million in global medical cannabis, reflecting a 15% year-over-year increase. Operationally, the company achieved a 52% rise in adjusted EBITDA and maintained a strong adjusted gross margin of 69% for medical cannabis. However, the company reported a net loss of $53.2 million, compared to a profit of $1.4 million in the same period last year, partly attributed to a decline in consumer cannabis revenue. Looking ahead, Aurora anticipates further growth supported by a strong cash balance and a focus on its medical cannabis business.
Read more →-ACB
Oct 22, 2025Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has announced a conference call to discuss its financial results for the second quarter of 2026, scheduled for November 5, 2025. The announcement highlights the company's focus on transparency and engagement with investors. Executive Chairman Miguel Martin and CFO Simona King will lead the call. The event follows the release of the company's financial results prior to market opening on the same day, reflecting Aurora's commitment to keeping shareholders informed.
Read more →-ACB
Sep 18, 2025Aurora Announces Investment into German Manufacturing Facility NASDAQ | TSX: ACB Facility investment includes adopting the company's unmatched global manufacturing practices for superior cannabis production and quality E
Aurora Cannabis Inc. has announced a significant investment over five years for operational upgrades to its EU-GMP manufacturing facility in Leuna, Germany. The investment aims to enhance flower growth capacity, product quality, and cost efficiency by adopting advanced manufacturing practices from its Canadian facilities. This move is expected to strengthen their supply chain and expand their capabilities in response to the growing demand for medical cannabis in Europe. Aurora Leuna, which currently operates under the IndiMed brand, will be able to grow additional cultivars thanks to these improvements.
Read more →-ACB
Aug 8, 2025▲ +6.4%on this news· ran to +31% by day 3
Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting NASDAQ | TSX
Aurora Cannabis Inc. announced the results of its 2025 Annual General and Special Meeting, where shareholder participation was noted at 31.53%. Most director nominees were elected, although Theresa Firestone resigned after failing to secure majority support. The meeting confirmed the appointment of Ernst & Young LLP as auditors and involved changes to executive plans. The board's leadership structure was adjusted with the appointment of new roles in the wake of these results.
Read more →-ACB
Aug 8, 2025▲ +6.4%on this news· ran to +31% by day 3
ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the "Company")
Aurora Cannabis Inc. held its annual general and special meeting, announcing significant shareholder voting results. The election of directors and appointment of auditors saw strong approvals, with most resolutions passing comfortably. However, the resignation of board member Theresa Firestone and the defeat of the advisory vote on executive compensation reveal some areas of concern among shareholders. The company plans to recruit another director to fill the vacancy left by Firestone.
Read more →-ACB
Aug 6, 2025▼ -7.9%on this newsshared move
Aurora Cannabis Announces Fiscal 2026 First Quarter Results NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue 1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue 1 by 85
Aurora Cannabis reported its financial results for Q1 of fiscal 2026, highlighting a 37% increase in global medical cannabis revenue to $64.8 million, driven by significant growth in international markets. The increase in adjusted EBITDA by over 200% reflects the company's profitable expansion strategies. However, the report noted a net loss of $19.4 million, compared to a profit in the previous year, primarily due to rising operating expenses and declining consumer cannabis revenues. Looking forward, the company anticipates continued revenue growth in its medical cannabis segment while managing costs effectively.
Read more →-ACB
Jul 30, 2025Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders Your vote is important no matter how many shares you own. Please v
Aurora Cannabis Inc. has issued a reminder to its shareholders about the upcoming proxy voting deadline for its 2025 Annual General and Special Meeting scheduled for August 8, 2025. Shareholders are encouraged to vote in advance by the deadline of August 6, 2025, and can seek assistance from the company's designated advisor, Laurel Hill Advisory Group. The board of directors is recommending that shareholders vote for all director nominees and proposed resolutions.
Read more →-ACB
Jul 23, 2025Aurora Cannabis to Host First Quarter 2026 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has announced it will host a conference call on August 6, 2025, to discuss its financial results for the first quarter of fiscal 2026. The call will include leadership from the company, including CEO Miguel Martin and CFO Simona King, and is intended to provide insights into the company's performance. This event reflects Aurora's commitment to transparency and maintaining investor relations. Financial results will be made public before the market opens that same day.
Read more →-ACB
Jul 14, 2025Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre Adding a fourth certified facility within its global network increases operational capacity to better serve international m
Aurora Cannabis has announced the successful EU-GMP certification of its dedicated distribution center in Brampton, Ontario. This marks the company's fourth certified facility within its global network, significantly increasing its operational capacity to better serve international medical markets. The certification aligns with the EU standards, enabling Aurora to enhance its export capabilities and assure consistent access to high-quality medical cannabis worldwide. The company's Vice President emphasized this achievement as a validation of its approach in the global market.
Read more →-ACB
Jul 9, 2025Letter from our Executive Chairman and CEO Dear Fellow Shareholders, We are pleased to invite you to the 2025 Annual General and Special Meeting of Shareholders of Aurora Cannabis Inc. (" Aurora " or the " Company ") to
Aurora Cannabis Inc. has announced that it will hold its 2025 Annual General and Special Meeting virtually on August 8, 2025. Shareholders eligible to vote must hold shares by June 16, 2025, and can participate in various business items such as electing directors and approving amendments to compensation plans. The company is implementing an environmentally friendly approach by using a notice-and-access system for meeting materials delivery. Additionally, the executive compensation structure highlights a significant emphasis on performance-based pay.
Read more →-ACB
Jul 9, 2025Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders Your vote is important no matter how many shares you own.
Aurora Cannabis Inc. has announced the filing and mailing of its management information circular in preparation for the upcoming annual general and special meeting of shareholders. The virtual meeting is scheduled for August 8, 2025, allowing all shareholders to participate and vote, regardless of their location. The company encourages shareholders to review the circular and cast their votes ahead of the deadline on August 6, 2025. Aurora's board recommends voting in favor of all director nominees and meeting resolutions.
Read more →-ACB
Jun 19, 2025▼ -12.8%on this news
Aurora Cannabis Advises of Second False Article from Investing.com NASDAQ | TSX
Aurora Cannabis Inc. has announced that it is addressing misinformation concerning two false articles published by Investing.com. The articles inaccurately claimed that Aurora had entered into agreements with MedLeaf Therapeutics and MediPharm GmbH. The company vehemently denies these claims and emphasizes that no such discussions or partnerships have occurred. Aurora is conducting an investigation to determine the source of this misinformation and warns investors against relying on Investing.com for credible information.
Read more →-ACB
Jun 18, 2025▼ -20.4%on this news· ran to -32% by day 3shared move
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth Delivers Reco
Aurora Cannabis has reported its financial results for the fourth quarter and fiscal year 2025, showcasing significant growth in global medical cannabis revenue. The company's net revenue for the year reached $244.4 million, reflecting a notable 39% increase, while adjusted EBITDA soared by 261% to $49.7 million. Despite these successes, Aurora experienced a net loss of $17.2 million during the quarter, though this was an improvement from the previous year. Additionally, the consumer cannabis segment saw a decline in revenue by 20%, prompting a strategic focus on higher-margin medical cannabis products.
Read more →-ACB
Jun 18, 2025▼ -20.4%on this news· ran to -32% by day 3shared move
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics NASDAQ | TSX
Aurora Cannabis announced that it has not agreed to acquire MedLeaf Therapeutics, addressing misinformation circulating on news websites. The company emphasized that there have been no discussions regarding a business combination with MedLeaf. Additionally, it has released its financial statements for the fourth quarter and fiscal year ending March 31, 2025. The announcement reinforces Aurora's commitment to transparency and its ongoing operations in the cannabis sector.
Read more →-ACB
Jun 3, 2025Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information NASDAQ | TSX
Aurora Cannabis announced plans to host a conference call on June 18, 2025, to discuss its financial results for the fourth quarter and fiscal year 2025. The company aims to provide investors with insights into its performance, following a report of results before market opening on the same day. Miguel Martin and Simona King will lead the discussion. Aurora continues to operate across medical and consumer markets globally.
Read more →-ACB
Mar 20, 2025▲ +5.3%on this news
Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard
Aurora Cannabis has announced a groundbreaking discovery of genetic resistance to powdery mildew, a major challenge in cannabis cultivation. The findings, developed at Aurora Coast in collaboration with researchers from The University of British Columbia, will enhance the company's breeding program and may lead to a commercial launch of new cultivars within the year. This advancement aims to improve disease management in cannabis production, reduce costs, and boost product quality. Aurora's investment in scientific research underpins its strategy to lead in the competitive cannabis market.
Read more →-ACB
Feb 14, 2025Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aur
Aurora Cannabis has made it easier for patients in Australia to access high-quality medical cannabis products by eliminating the concession card requirement for its IndiMed brand. This change allows any patient to be prescribed these products, enhancing overall accessibility. The IndiMed portfolio has been successfully expanding since its launch in 2021, and the company is proud to maintain compliance with TGA-GMP standards. Aurora's strategic maneuver reflects its dedication to adapting to market needs and improving patient care.
Read more →-ACB
Feb 6, 2025▲ +16.4%on this news
Aurora Cannabis Announces Supply Agreement with SNDL NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB
Aurora Cannabis has entered into a strategic supply agreement with SNDL Inc., a Canadian vertically integrated cannabis enterprise, to supply premium cannabis flower products. This three-year agreement, valued at approximately $27 million, aims to complement their existing relationship focused on quality and cultivation excellence. The deal comes after Aurora's strong performance, particularly in the international medical cannabis segment. Both companies emphasize their commitment to quality as they expand their collaborative efforts in the cannabis industry.
Read more →-ACB
Feb 5, 2025▲ +45.9%on this news· ran to +80% by day 3shared move
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results NASDAQ | TSX: ACB Reports Total Net Revenue 1 of $88.2 Million, up 37% YoY, Including Record Net Revenue 1 of $68.1 Million in Global Medical Cannabis, up 51% Y
Aurora Cannabis reported its fiscal 2025 third quarter results, achieving record total net revenue of $88.2 million, a 37% increase year-over-year, and a net income of $31.2 million, which represents a remarkable 282% growth. The company highlighted a significant contribution from its global medical cannabis business, which recorded a 51% increase in revenue. With a strong cash position and debt-free operations, Aurora also reported achieving its target for positive free cash flow during the quarter. Looking ahead, the company anticipates continued revenue growth and a stable operating model in the upcoming quarters.
Read more →-ACB
Jan 22, 2025Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has announced a conference call to discuss its financial results for the third quarter of 2025. Scheduled for February 5, 2025, at 8:00 a.m. Eastern Time, the call will feature the company's executive leadership including the CEO and CFO. This investor event aims to provide updates and insights into Aurora's operational performance in a key financial period. The company continues to expand its market presence in both medical and recreational cannabis sectors.
Read more →-ACB
Nov 6, 2024▼ -16.2%on this news
Aurora Cannabis Announces Fiscal 2025 Second Quarter Results NASDAQ | TSX: ACB Record Adjusted EBITDA 1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue 1 up 29% YoY to $81.1 Million, with 41% growth in Glo
Aurora Cannabis reported strong financial results for the second quarter of fiscal 2025, highlighting a record adjusted EBITDA of $10.1 million, which represents a 210% year-over-year increase. Quarterly net revenue rose by 29% to reach $81.1 million, driven by a substantial 41% increase in its global medical cannabis segment and a notable 93% growth in international revenue. The company reaffirmed its target of achieving positive free cash flow by the end of December 2024. Overall, Aurora's financial performance showcases its effective strategy in capitalizing on growth opportunities in rapidly expanding international markets.
Read more →-ACB
Oct 24, 2024Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call NASDAQ | TSX
Aurora Cannabis has announced that it will hold a conference call on November 6, 2024, to discuss its financial results for the second quarter of the fiscal year 2025. The call will be led by CEO Miguel Martin and CFO Simona King. Financial results will be released before the market opens that same day, providing an opportunity for investors to engage with company leaders. This announcement underscores Aurora's commitment to transparency and investor relations in the cannabis industry.
Read more →-ACB
Sep 20, 2024Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMON
Aurora Cannabis announced that CEO Miguel Martin will also serve as Executive Chairman of the Board, while outgoing Chairman Ron Funk will transition to Lead Independent Director. This change, effective immediately and unanimously approved by the Board, aims to strengthen leadership and decision-making as the company focuses on global growth. Martin has led significant changes and recovery efforts since 2020, positioning the company well within the challenges faced in the cannabis industry. Funk's continued involvement is expected to support effective governance during this transition.
Read more →-ACB
Sep 17, 2024Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors
Aurora Cannabis is making significant advancements in auto-flowering research, aiming to enhance cannabis cultivation, especially in high-latitude regions. The company has received a US patent that allows for the identification of the auto-flowering trait, which could revolutionize outdoor cultivation. Their innovative approaches are not only focused on improving yield but also on reducing production costs and enhancing the adaptability of cannabis crops. These developments reinforce Aurora's position as a leader in the cannabis industry and highlight its commitment to scientific research.
Read more →-ACB
Aug 26, 2024FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change
Aurora Cannabis has announced a commercial collaboration with Cogent International Manufacturing, aiming to launch a new CBD lozenge on its Canadian medical cannabis platform. This initiative is expected to provide valuable patient feedback and real-world data that can validate the product proposition. The collaboration is planned to last for 24 months and may expand into future product offerings from Vectura Fertin Pharma. This partnership could enhance Aurora's positioning in the medical cannabis market through the introduction of innovative products.
Read more →-ACB
Aug 12, 2024Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting NASDAQ | TSX
Aurora Cannabis Inc. reported the successful results of its 2024 Annual General and Special Meeting of Shareholders held virtually on August 9, 2024. Shareholders approved all proposed matters, including the election of directors and the appointment of Ernst & Young LLP as auditors for the upcoming year. The meeting had an engagement level of 27.23% of shares, showcasing significant shareholder participation. The approved resolutions also included amendments to the Company's equity incentive plans and the renewal of the Shareholder Rights Plan.
Read more →-ACB
Aug 7, 2024▲ +6.3%on this news· ran to +20% by day 1shared move
Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow Delivers Positive Free Cash Flow 1 of $6.5 Million Increases Total Quarterly Net Revenue 1 by 12% YoY to $83.4 Million, Rec
Aurora Cannabis reported strong financial results for the first quarter of fiscal 2025, showing positive free cash flow of $6.5 million and a 12% increase in total net revenue to $83.4 million. The company highlighted record net revenue in the global medical cannabis sector, contributing significantly to its growth. Additionally, consolidated adjusted EBITDA increased to $4.9 million, reflecting operational efficiency and strategic market expansion. The positive results reinforce Aurora's commitment to maintaining momentum throughout the fiscal year.
Read more →-ACB
Aug 1, 2024Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration Collaboration will initially see launch of a new CBD lozenge from Cogent International, a Vectura Fertin Pharma subsidiary, on Aurora's Ca
Aurora Cannabis Inc. has entered into a commercial collaboration with Vectura Fertin Pharma to launch a new CBD lozenge via Cogent International, its subsidiary. The collaboration aims to leverage Aurora’s patient platform for obtaining real-world feedback on the product. Should the launch succeed, the companies plan to explore further opportunities for other medical cannabis products. The initial agreement has a term of 24 months, focusing on future product development and validation in the Canadian medical cannabis market.
Read more →-ACB
Jul 29, 2024Aurora Cannabis to Host First Quarter 2025 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has scheduled a conference call for August 7, 2024, to discuss its financial results for the first quarter of 2025. The company will report its financial outcomes ahead of the market opening on the same day. Key executives, including the CEO and CFO, will host the conference call, offering insights and a Q&A for investors.
Read more →-ACB
Jul 25, 2024Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility NASDAQ | TSX: ACB Company's Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Rese
Aurora Cannabis has been granted expanded cultivation and research licenses by the German Federal Institute for Drugs and Medical Devices. This allows the company to enhance local production and conduct research on new cannabis cultivars at its facility in Leuna, Germany. The licenses come amidst a growing medical cannabis market in Germany, facilitating better access for patients. Aurora highlights its ongoing commitment to quality and compliance as key factors for receiving these licenses.
Read more →-ACB
Jul 9, 2024▲ +8.1%on this news· ran to +21% by day 3
CEO Letter to Shareholders Dear Shareholders, We are pleased to invite you to the 2024 Annual General and Special Meeting of Shareholders of Aurora Cannabis Inc. (" Aurora " or the " Company ") to be held on Friday
Aurora Cannabis invites shareholders to its 2024 Annual General and Special Meeting, highlighting significant achievements from the past fiscal year. The company has achieved its strongest performance to date and is now debt-free, positioning itself for profitable growth. Emphasizing stability and innovation, Aurora has made strides in its medical cannabis strategy and expanded its international reach. The upcoming meeting will address key organizational matters and continue to focus on shareholder engagement.
Read more →-ACB
Jul 9, 2024▲ +8.1%on this news· ran to +21% by day 3
Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders NASDAQ | TSX: ACB Your vote is important no matter how m
Aurora Cannabis Inc. has announced the filing and mailing of its management information circular ahead of its upcoming annual general and special meeting of shareholders scheduled for August 9, 2024. The circular is available on the company's website and is designed to inform shareholders about essential matters needing their vote. Aurora's management highlights its achievements in stabilizing the company and emphasizes a strategy focused on profitable growth, aiming for positive free cash flow by the end of 2024. Shareholders are encouraged to review the circular and cast their votes ahead of the deadline on August 7, 2024.
Read more →-ACB
Jun 25, 2024▼ -7.5%on this news
AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR TO: Ernst & Young LLP 1133 Melville Street, Suite 1900 Vancouver, BC V6E 4E5 AND TO: KPMG LLP PO Box 10426, 777 Dunsmuir Street Vancouver, BC V7Y 1K3 AND TO: Alberta Secur
Aurora Cannabis Inc. has officially announced a change of auditors, transitioning to Ernst & Young LLP and KPMG LLP. This change is in accordance with the necessary regulatory requirements and has been communicated to multiple securities commissions across Canada. The notice is signed by Simona King, the Chief Financial Officer of the company, and reflects the company's ongoing compliance with financial regulations. This action does not signal any immediate changes in the operational strategy of Aurora Cannabis.
Read more →-ACB
Jun 20, 2024Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter Delivers Record Annual Adjusted EBITDA 1 of $12.8 Million NASDAQ | TSX: ACB Q4 Represents the Sixth Consecutive Quarter of Positive Adjuste
Aurora Cannabis announced its fiscal 2024 fourth quarter results, showcasing a record annual adjusted EBITDA of $12.8 million. The company experienced a 21% increase in net revenue compared to the previous fiscal year, attributed mainly to growth in its global medical cannabis operations. Despite record performance, consumer cannabis revenue faced a decline of 29%, impacting overall margins. Aurora aims to achieve positive free cash flow by the end of calendar year 2024, supported by a robust balance sheet and strategic global expansion.
Read more →-ACB
Jun 7, 2024▼ -5.5%on this news
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information NASDAQ | TSX
Aurora Cannabis Inc. has announced an investor conference call to discuss its fourth quarter and fiscal year 2024 results, scheduled for June 20, 2024. The company will release its financial results before the market opens that day. This call will be hosted by CEO Miguel Martin and CFO Simona King. As part of its communication strategy, Aurora aims to keep investors informed about its financial performance and future prospects.
Read more →-ACB
May 15, 2024Aurora Cannabis Announces Appointment of New Director NASDAQ | TSX: ACB Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB
Aurora Cannabis has appointed Rajesh Uttamchandani to its Board of Directors as part of a newly created directorship. Uttamchandani brings extensive experience in strategy development, human capital, and innovation from various sectors, including technology and education. His past roles include positions at ApplyBoard and MaRs Discovery District, showcasing a robust background suitable for Aurora's strategic goals. The appointment is intended to enhance Aurora's efforts towards sustainable performance and leadership in the cannabis market.
Read more →-ACB
May 8, 2024Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Launches Premium Products Redefining Patient Care EDMONTON, AB
Aurora Cannabis has successfully launched its first medical cannabis shipment to New Zealand, marking a pivotal moment for accessibility in the region. This inaugural line includes premium dried cannabis flowers aimed at addressing various patient needs, reflecting Aurora's dedication to quality and care. The CEO expressed enthusiasm about the potential for growth in the New Zealand market, similar to their experience in Australia. Overall, the launch positions Aurora as a leader in the emerging New Zealand cannabis sector.
Read more →-ACB
Apr 17, 2024AURORA CANNABIS INC. NOTICE OF CHANGE OF AUDITOR TO: KPMG LLP PO Box 10426, 777 Dunsmuir Street Vancouver, BC V7Y 1K3 AND TO: Alberta Securities Commission British Columbia Securities Commission Manitoba Securities Commi
Aurora Cannabis Inc. has issued a notice of change of auditor, signaling a transition to KPMG LLP as its new auditing firm. This change was communicated to several securities commissions across Canada, including the Alberta and British Columbia Securities Commissions. The notice adheres to National Instrument 51-102 Continuous Disclosure Obligations, ensuring compliance with regulatory requirements. The firm's Chief Financial Officer, Simona King, signed the notice, formalizing the transition.
Read more →-ACB
Feb 29, 2024Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1] NASDAQ | TSX
Aurora Cannabis Inc. has announced the successful completion of the final repayment of approximately $7.2 million for its convertible senior notes, marking a total repayment of around $465 million since 2021. This milestone signifies that Aurora's cannabis operations are now debt-free, apart from a remaining $47.9 million debt related to Bevo Farms. The CEO highlighted the financial discipline that has enabled this achievement and expressed optimism regarding the company's goal of attaining positive free cash flow in the upcoming year.
Read more →-ACB
Feb 20, 2024▼ -11.7%on this news
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation NASDAQ | TSX
Aurora Cannabis has announced the appointment of Simona King as Chief Financial Officer, effective February 21, 2024. Ms. King, who comes with over 25 years of experience including a long tenure at Bristol Myers-Squibb, is expected to lead the company's next phase of growth. Additionally, Aurora completed a share consolidation at a 10 to 1 ratio, with shares beginning to trade on a post-consolidation basis on NASDAQ and TSX. Current CFO Glen Ibbott will transition to an advisory role to ensure a smooth handover of responsibilities.
Read more →-ACB
Feb 8, 2024FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 Date of Material Change February 7 , 2024 I
Aurora Cannabis Inc. reported a significant material change involving the acquisition of the remaining 90% equity interest in Indica Industries Pty Ltd, known as MedReleaf Australia. This acquisition, valued at AUD$50 million, was executed through a combination of cash payment and share issuance. The company aims to expand its footprint in the medical cannabis sector through this strategic purchase. Further details can be accessed through company communications and press releases.
Read more →-ACB
Feb 8, 2024Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow 1 This Calendar Year, Delivers Fi
Aurora Cannabis announced its financial results for the third quarter of fiscal 2024, showcasing a record adjusted EBITDA of $4.3 million and a 41% increase in international medical cannabis revenue year-over-year. The company reaffirmed its commitment to achieving positive free cash flow by the end of this calendar year. Notably, Aurora's acquisition of MedReleaf Australia enhances its market position as the largest global medical cannabis company. However, the firm still incurred a net loss of $25.2 million, despite improved profitability metrics in its operations.
Read more →-ACB
Feb 8, 2024Aurora Cannabis Acquires MedReleaf Australia NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannab
Aurora Cannabis has acquired the remaining 90% equity interest in MedReleaf Australia, enhancing its position as the largest global medical cannabis company. This acquisition, valued at AUD $50 million, is anticipated to positively impact Aurora's Adjusted EBITDA and accelerate its path to positive free cash flow in 2024. MedReleaf Australia, a leading distributor in the Australian market, is set to bolster Aurora's growth strategy in key APAC regions. This strategic milestone reflects Aurora's commitment to investing in rapidly growing markets for sustainable and profitable growth.
Read more →-ACB
Jan 31, 2024Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA 1 for fiscal 2024 and Pos
Aurora Cannabis has provided a business update confirming expectations for positive annual Adjusted EBITDA and free cash flow in 2024. The company scheduled its third quarter fiscal year 2024 investor conference call for February 8, 2024, and announced a share consolidation plan to improve compliance with Nasdaq listing requirements. This consolidation will convert every 10 outstanding shares into a single common share, effective around February 20, 2024. CEO Miguel Martin emphasized ongoing financial discipline as a priority for future growth.
Read more →-ACB
Nov 9, 2023▼ -5%on this news
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA NASDAQ | TSX: ACB Delivers Record Positive Adjusted EBITDA 1 of $3.4 Million Quarterly Net Revenue 1 rose 30% YoY
Aurora Cannabis has reported strong financial results for Q2 fiscal 2024, achieving record positive adjusted EBITDA of $3.4 million and a net revenue increase of 30% year-over-year, totaling $63.4 million. Significant growth was noted in the medical cannabis segment, attributed to expanded operations in Europe and Australia. The company is poised for continued growth through anticipated annualized cost efficiencies and a robust balance sheet. However, a decline in consumer cannabis revenue has been observed, suggesting areas for strategic improvement moving forward.
Read more →-ACB
Oct 26, 2023Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call NASDAQ | TSX
Aurora Cannabis Inc. has announced a conference call scheduled for November 9, 2023, to discuss its financial results for the second quarter of fiscal year 2024. The call will occur at 5:00 p.m. Eastern Time, following the release of the results after market close. This initiative demonstrates Aurora's commitment to keeping investors informed about its performance and future direction.
Read more →-ACB
Sep 19, 2023Aurora Confirms Approval of Transfer to Nasdaq Capital Market; Enters into Agreement to Repurchase a Further ~ US$9.6 Million Principal Amount of Convertible Notes NASDAQ | TSX
Aurora Cannabis Inc. has confirmed its approval to transfer its common shares from the Nasdaq Global Select Market to the Nasdaq Capital Market. This transfer, effective September 19, 2023, provides an additional 180 days for the company to meet compliance with the Minimum Bid Price Requirement. Additionally, Aurora announced a repurchase agreement for approximately $9.6 million in convertible senior notes, signaling a move to reduce its debt and achieve positive free cash flow by 2024. The company's shares will continue trading under the ticker 'ACB' on both Nasdaq and TSX without disruption.
Read more →-ACB
Sep 8, 2023▲ +14.8%on this news· ran to +98% by day 1
Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding NASDAQ | TSX
Aurora Cannabis Inc. announced the repurchase of approximately $9 million of its convertible notes, aiming to decrease debt and cash interest costs. This strategic move is part of Aurora's broader initiative to achieve positive free cash flow by 2024, with the company's outstanding notes now reduced to about $39 million. Since December 2021, Aurora has repurchased a total of $419 million in notes, resulting in significant interest savings. The CEO expressed confidence in the company's strong financial position and management practices.
Read more →-ACB
Aug 14, 2023Aurora Cannabis Announces Results of 2023 Annual General Meeting NASDAQ | TSX
Aurora Cannabis announced the results of its 2023 Annual General Meeting held virtually on August 14, 2023. Shareholders approved all resolutions presented, including the election of directors and the appointment of KPMG LLP as auditors. The meeting saw a turnout of 92,897,315 shares, representing 26.23% of the company's outstanding common shares. Aurora continues its focus on cannabis for both medical and consumer markets, maintaining a varied brand portfolio.
Read more →-ACB
Aug 10, 2023AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended
Aurora Cannabis Inc. has released its condensed consolidated interim financial statements for the quarter ending June 30, 2023. The company reported a notable increase in revenue, rising to CAD 81.6 million from CAD 57.5 million during the same period last year. However, it continues to face significant net losses, totaling CAD 28.3 million, although this is an improvement from previous losses. The company's financial position indicates a reduction in total liabilities, yet it remains under pressure with declining equity attributable to shareholders.
Read more →-ACB
Aug 10, 2023Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA Achieves Quarterly Net Revenue 1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Can
Aurora Cannabis reported its financial results for the first quarter of fiscal 2024, highlighting a significant increase in net revenue, which rose by 50% year-over-year to $75.1 million. The company achieved a record positive adjusted EBITDA of $2.2 million for the quarter, marking the third consecutive quarter of positive adjusted EBITDA. Notable growth was observed across all business units, particularly in medical cannabis where revenue increased by 14%. Despite a net loss of $28.3 million, improvements in operational costs have positioned Aurora favorably for continued growth in the upcoming fiscal year.
Read more →-ACB
Jul 27, 2023Aurora Cannabis to Host First Quarter Fiscal Year 2024 Investor Conference Call NASDAQ| TSX
Aurora Cannabis Inc. has announced an investor conference call scheduled for August 10, 2023, to discuss its first quarter results for fiscal year 2024. The call will be led by CEO Miguel Martin and CFO Glen Ibbott, with financial results to be released after market close on the same date. This event underscores the company's commitment to transparency with investors while continuing its focus on innovation and quality in the cannabis sector.
Read more →-ACB
Jul 24, 2023Aurora Cannabis Announces Sale of Aurora Sun Facility to Bevo Expected to Provide Incremental Revenue and Cash Flow NASDAQ | TSX
Aurora Cannabis has finalized the sale of its Aurora Sun Facility to Bevo Farms, which is expected to enhance Aurora's cash flow and provide up to $15 million in potential incremental revenue. The transaction aligns with Bevo's growth strategy, enabling them to capitalize on the Alberta greenhouse industry. Aurora's CEO, Miguel Martin, expressed optimism regarding the synergies created through this partnership. The facility's sale is also anticipated to reduce Aurora's annual carrying costs by approximately $2 million.
Read more →-ACB
Jul 19, 2023Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders Your vote is important no matter how many shares you own. Vote today.
Aurora Cannabis Inc. has announced the filing and mailing of its Management Information Circular in preparation for its upcoming Annual General Meeting (AGM) of shareholders, scheduled for August 14, 2023. The company emphasizes the importance of shareholder participation and has made resources available for assistance with voting. The meeting will take place in a virtual format to encourage broad participation among shareholders, regardless of their geographic location. Detailed instructions and proposals for shareholder voting are outlined in the Circular.
Read more →-ACB
Jun 14, 2023▼ -7.9%on this news
Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results NASDAQ | TSX: ACB Achieves Second Sequential Quarter of Positive Adjusted EBITDA 1 Net Revenue Reaches $64 Million, Increasing 4% Sequential
Aurora Cannabis announced its financial results for the third quarter of fiscal 2023, highlighting positive earnings and revenue growth. The company reported a net revenue of $64 million, up 4% sequentially, and achieved two consecutive quarters of positive Adjusted EBITDA. Aurora's cost efficiencies have strengthened its balance sheet, with $230 million in cash on hand. However, the company also reported a net loss of $87 million, primarily due to increased expenses and decreased revenues in certain segments.
Read more →-ACB
Jun 7, 2023Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information NASDAQ | TSX
Aurora Cannabis Inc. has announced a conference call scheduled for June 14, 2023, to discuss its financial results for the third quarter and full fiscal year 2023. The call will feature CEO Miguel Martin and CFO Glen Ibbott, providing a platform for investor engagement. The company aims to enhance transparency by reporting its financial performance prior to the stock market opening. Aurora continues to expand its brand portfolio and serves both medical and recreational cannabis markets.
Read more →-ACB
Apr 28, 2023Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs NASDAQ | TSX
Aurora Cannabis Inc. has expanded its medical cannabis offerings in Germany by launching two new high-THC flower products, Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA, aimed at meeting the specific needs of patients requiring tailored treatments. This expansion is indicative of Aurora's focus on providing a broad spectrum of cannabis products and reinforces its commitment to quality and consistency in patient care. The product additions come as part of a strategy to solidify its leadership in the international medical cannabis market.
Read more →-ACB
Apr 24, 2023Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in C
Aurora Cannabis Inc. has announced the repurchase of approximately $22.3 million of its convertible notes, resulting in significant annual interest savings of about $2.6 million. This initiative aims to reduce the company's debt and reinforce their financial discipline while leaving around $79 million of notes outstanding. Aurora has made substantial progress in debt reduction, having repurchased approximately $385 million in notes since December 2021. The company continues to focus on profitable growth in both global medical and Canadian adult-use markets.
Read more →-ACB
Mar 30, 2023Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry NASDAQ | TSX
Aurora Cannabis announced the repurchase of approximately $46.6 million in convertible senior notes, saving the company $2.6 million in annualized interest payments. This transaction, completed at a 2.5% discount to par value, reflects the company's ongoing commitment to reducing debt and maintaining financial discipline. Following this repurchase, Aurora's outstanding notes will total around $103 million, bolstering its already strong balance sheet. The company aims to continue focusing on profitable growth in both global medical and Canadian adult use markets.
Read more →-ACB
Mar 24, 2023Aurora Provides Update on Nasdaq Listing NASDAQ | TSX
Aurora Cannabis Inc. has announced it received a Notification Letter from Nasdaq, indicating non-compliance with the Minimum Bid Price Requirement due to its stock price falling below US$1.00 for 30 consecutive trading days. The Company has until September 20, 2023, to address this issue. While the Notification Letter does not impact trading or the status of its shares on the Toronto Stock Exchange, Aurora is monitoring its stock price closely and exploring options to regain compliance.
Read more →-ACB
Mar 17, 2023Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus NASDAQ | TSX
Aurora Cannabis Inc. has announced the filing of a new preliminary base shelf prospectus, which will allow the company to issue up to $650 million in securities over the next 25 months. This filing includes the registration of various financial instruments, such as common shares and warrants, which will replace the existing base shelf prospectus. Approximately $412 million will be allocated to the exercise of outstanding warrants, while around $238 million is earmarked for new issuances. The move is intended to strengthen Aurora's position in both the medical and consumer cannabis markets.
Read more →-ACB
Feb 22, 2023Aurora and MedReleaf Australia Launch new Medical Cannabis Brand - CraftPlant NASDAQ | TSX: ACB Canada's leading medical cannabis provider and Australia's preeminent medical cannabis supplier to bring three new premium s
Aurora Cannabis Inc. has launched a new medical cannabis brand named CraftPlant in collaboration with MedReleaf Australia. This brand features three new THC-dominant strains—Greendae, Navana, and HiVolt—specifically developed for the Australian market. The products are produced under stringent EU-GMP certified conditions and aim to provide innovative solutions for patients seeking alternative treatments. Aurora is committed to expanding its presence and offerings within the promising Australian cannabis market.
Read more →-ACB
Feb 10, 2023AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended
Aurora Cannabis Inc. recently released its interim financial results for the quarter and six months ending December 31, 2022. The company reported a substantial net loss of $67,183, coupled with a gross loss of $16,170. Additionally, total liabilities have seen a slight increase, while total equity has declined. These results indicate ongoing financial challenges and underscore the company's struggles in managing costs relative to revenue generation.
Read more →-ACB
Feb 9, 2023▼ -6.2%on this newsshared move
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results NASDAQ | TSX: ACB Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue 1 of $61.7 Million Achieves Positive Adjusted EBITDA 1 in Line with Prior Guidance
Aurora Cannabis reported its fiscal Q2 2023 results, highlighting a significant revenue increase of approximately 20% from the previous quarter, totaling $61.7 million. The company achieved a positive adjusted EBITDA of $1.4 million, driven by strong performance across its cannabis segments and a successful operational efficiency plan. Despite a net loss of $67.2 million, Aurora indicated improved financial health with a net cash position and substantial cost savings realized. Looking forward, the company aims to focus on profitable growth opportunities and discipline in capital deployment.
Read more →-ACB
Jan 26, 2023Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call EDMONTON, AB
Aurora Cannabis Inc. has scheduled a conference call to review its financial performance for the second quarter of fiscal year 2023, set for February 9, 2023. The call will be led by CEO Miguel Martin and CFO Glen Ibbott. Aurora is known for its diverse product offerings in both medical and recreational cannabis markets, and the call aims to provide insights into its financial health and operational strategies. The company's common shares are traded on NASDAQ and TSX under the ticker symbol 'ACB'.
Read more →-ACB
Jan 4, 2023Aurora Cannabis Announces Sale of Polaris Facility - Balance Sheet Remains Among Strongest in Industry NASDAQ | TSX
Aurora Cannabis Inc. has announced the successful sale of its Polaris facility, generating approximately $15 million in proceeds. The transaction is part of the company’s ongoing transformation efforts. Aurora's financial position remains robust, with around $320 million in cash and cash equivalents, bolstering its outlook for reaching Adjusted EBITDA profitability in the near future. As a key player in the cannabis industry, Aurora continues to strengthen its market presence.
Read more →-ACB
Dec 5, 2022Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry NASDAQ | TSX: ACB Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive
Aurora Cannabis Repurchases ~$103 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction EDMONTON, AB, Dec. 5, 2022 /CNW/ - Aurora Cannabis Inc. (
Read more →-ACB
Nov 28, 2022▼ -6.1%on this news
AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 11,500,000 Warrants
AURORA CANNABIS INC. COMPUTERSHARE TRUST COMPANY OF CANADA Providing for the Issue of Page ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Words Importing the Singular 6 1.3 Interpretation not Affected by Headings 6 1.4 Day not a Business Day 7 1.5 Time of t
Read more →-ACB
Nov 14, 2022Aurora Cannabis Announces Results of 2022 Annual General and Special Meeting NASDAQ | TSX
Aurora Cannabis Announces Results of 2022 Annual General and Special Meeting EDMONTON, AB, Nov. 14, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announ
Read more →-ACB
Nov 10, 2022▲ +8.3%on this news· ran to +27% by day 3shared move
Aurora Cannabis Announces Fiscal 2023 First Quarter Results NASDAQ | TSX: ACB Reiterates Reaching Adjusted EBITDA Profitability by
Aurora Cannabis Announces Fiscal 2023 First Quarter Reaching Adjusted EBITDA Profitability by December 31, 2022 $150 to $170 Million in Annualized Cost Savings Achieved by December 31, 2022; $140 Million Realized to Date Balance Sheet Through Accretive Debt Reduction of Approx
Read more →-ACB
Oct 27, 2022Aurora Cannabis to Host First Quarter Fiscal Year 2023 Investor Conference Call NASDAQ | TSX
Aurora Cannabis to Host First Quarter Fiscal Year 2023 Investor Conference Call EDMONTON, AB, Oct. 27, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today t
Read more →-ACB
Oct 18, 2022Aurora Cannabis Announces Mailing of Management Information Circular for the Annual and Special Meeting of Shareholders NASDAQ | TSX
Aurora Cannabis Announces Mailing of Management Information Circular for the Annual and Special Meeting of Shareholders EDMONTON, AB, Oct. 18, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of ca
Read more →-ACB
Oct 7, 2022▼ -12.8%on this news
Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry NASDAQ | TSX: ACB Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretiv
Aurora Cannabis Repurchases ~US$23 Million Principal Amount of Convertible Notes; Balance Sheet Among Strongest in Industry Balance Sheet Remains in Net Cash Position, Further Strengthened with Accretive Debt Reduction EDMONTON, AB, Oct. 7, 2022 /CNW/ - Aurora Cannabis Inc.
Read more →-ACB
Sep 20, 2022Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 a
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from Reiterates Adjusted EBITDA Profitability
Read more →-ACB
Aug 29, 2022▲ +5.2%on this news
Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2022 Investor Conference Call and Related Year End Informational Filings NASDAQ | TSX
Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2022 Investor Conference Call and Related Year End Informational Filings EDMONTON, AB, Aug. 29, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the
Read more →-ACB
Aug 25, 2022▲ +8.3%on this newsshared move
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 500-10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2 Date of Material Change
MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. ("Aurora" or 500-10355 Jasper Avenue Item 2 Date of Material Change A press release describing the material change was disseminated by Aurora on August 25, 2022 through Cision PR Newswire and can
Read more →-ACB
Aug 25, 2022▲ +8.3%on this newsshared move
Aurora Cannabis Acquires Controlling Interest in Bevo Farms NASDAQ | TSX: ACB Long Term Investment Expected to Deliver Aurora Immediate Positive Cash Flow Aurora acquires a controlling interest in Bevo; one of the larges
Aurora Cannabis Acquires Controlling Interest Long Term Investment Expected to Deliver Aurora Immediate Positive Cash Flow Aurora acquires a controlling interest in Bevo; one of the largest suppliers of propagated vegetables and ornamental plants in North America with proven
Read more →-ACB
Jun 3, 2022Aurora Cannabis Repurchases US$20 Million of Convertible Notes Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction EDMONTON, AB
Aurora Cannabis Repurchases US$20 Million of Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction EDMONTON, AB, June 3, 2022 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannab
Read more →-ACB
Jun 1, 2022▼ -5.4%on this newsshared move
AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 70,408,750 Warrants
AURORA CANNABIS INC. COMPUTERSHARE TRUST COMPANY OF CANADA Providing for the Issue of Page ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Words Importing the Singular 6 1.3 Interpretation not Affected by Headings 6 1.4 Day not a Business Day 7 1.5 Ti
Read more →-ACB
May 27, 2022▼ -38.5%on this newsshared move
EXECUTION VERSION 61,225,000 Units Aurora Cannabis Inc.
Aurora Cannabis Inc. UNDERWRITING AGREEMENT Canaccord Genuity Corp. ATB Capital Markets Inc. Cantor Fitzgerald Canada Corporation CIBC World Markets Inc. Nicolaus Canada Inc. c/o Canaccord Genuity Corp. c/o BMO Nesbitt Burns Inc. King Street West, 3rd Floor Ladies and G
Read more →-ACB
May 26, 2022Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing EDMONTON, AB
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing EDMONTON, AB, May 26, 2022 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has announced today that it ha
Read more →-ACB
May 18, 2022▼ -5.5%on this news
Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility State-of-the-art facility readying first delivery of medical grade cannabis for German patients
Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility State-of-the-art facility readying first delivery of medical grade cannabis for German patients EDMONTON, AB, May 18, 2022 /CNW/ - Aurora Cannabis Inc
Read more →-ACB
May 13, 2022▲ +17.4%on this newsshared move
AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended
AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements For the three and nine months ended March 31, (in Canadian Dollars) Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Comprehensive Loss 4 Con
Read more →-ACB
May 12, 2022▲ +5.7%on this news· ran to +35% by day 3shared move
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to
Aurora Cannabis Announces Fiscal 2022 Third Quarter EDMONTON, AB, May 12, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational r
Read more →-ACB
May 5, 2022▼ -8.2%on this news
Aurora Cannabis Advances Premiumization Strategy by Completing Acquisition of Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction NASDAQ | TSX
Aurora Cannabis Advances Premiumization Strategy by Completing Acquisition of Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction EDMONTON, AB, May 5, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB),
Read more →-ACB
May 3, 2022Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call EDMONTON, AB
Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call EDMONTON, AB, May 3, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today tha
Read more →-ACB
Mar 22, 2022▲ +6.1%on this news· ran to +29% by day 3
Aurora Cannabis Advances Premiumization Strategy by Acquiring Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction Thrive's highly experienced and trusted cannabis team in craft culti
Aurora Cannabis Advances Premiumization Strategy by Acquiring Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction Thrive's highly experienced and trusted cannabis team in craft cultivation, product innovation, and operational execution wil
Read more →-ACB
Feb 10, 2022Aurora Cannabis Announces Fiscal 2022 Second Quarter Results Global Cannabis Net Revenue of $60.6 Million Adjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adjusted EBITDA
Aurora Cannabis Announces Fiscal 2022 Second EDMONTON, AB, Feb. 10, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results
Read more →-ACB
Feb 3, 2022▼ -7%on this news
Aurora Cannabis's Reliva Expands Portfolio with New CBD Brand, KG7 NASDAQ | TSX: ACB Sports-oriented KG7 now available at relivacbd.com and in convenience stores across the
Aurora Cannabis's Reliva Expands Portfolio with Sports-oriented KG7 now available at relivacbd.com and in convenience stores across the U.S. EDMONTON, AB, Feb. 3, 2022 /CNW/ - Reliva, a leading American CBD brand and subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB)
Read more →-ACB
Feb 1, 2022▲ +7.5%on this newsshared move
Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call NASDAQ | TSX
Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call EDMONTON, AB, Feb. 1, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today t
Read more →-ACB
Jan 4, 2022Aurora Cannabis Delivers ~$10 Million Shipment of Medical Cannabis to Israel NASDAQ | TSX: ACB Believed to be the largest shipment of medical cannabis to Israel to-date Aurora continues to advance strategic leadership in
Aurora Cannabis Delivers ~$10 Million Shipment of Medical Cannabis to Israel - Believed to be the largest shipment of medical cannabis to Israel to-date - Aurora continues to advance strategic leadership in the global cannabinoid industry EDMONTON, AB, Jan. 4, 2022 /CNW/ - A
Read more →-ACB
Jan 4, 2022Aurora Cannabis Announces New Director and Updates to The Board Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive NASDAQ | TSX
Aurora Cannabis Announces New Director and Updates Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive EDMONTON, AB, Jan. 4, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining
Read more →-ACB
Dec 14, 2021Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis EDMONTON, AB
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis EDMONTON, AB, Dec. 14, 2021 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aur
Read more →-ACB
Nov 16, 2021Aurora Builds on a Decade of Global Leadership in Plant Genetics with the Launch of Occo Genetics and licensing business will be led by new hire, Casey Whelan, VP, Genetics Business Development EDMONTON, AB
Aurora Builds on a Decade of Global Leadership in Plant Genetics with the Launch of Occo Genetics and licensing business will be led by new hire, Casey Whelan, VP, Genetics Business Development EDMONTON, AB, Nov. 16, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Auror
Read more →-ACB
Nov 12, 2021▲ +12.3%on this newsshared move
ANNUAL GENERAL MEETING OF SHAREHOLDERS OF AURORA CANNABIS INC. (the "Company")
ANNUAL GENERAL MEETING OF SHAREHOLDERS AURORA CANNABIS INC. Pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations ("NI 51-102") In accordance with section 11.3 of NI 51-102 and following the annual general meeting of the holders of common s
Read more →-ACB
Nov 12, 2021▲ +12.3%on this newsshared move
Aurora Cannabis Announces Results of 2021 Annual General Meeting NASDAQ | TSX
Aurora Cannabis Announces Results of 2021 Annual EDMONTON, AB, Nov. 12, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from it
Read more →-ACB
Nov 9, 2021Aurora Cannabis Announces Fiscal 2022 First Quarter Results Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net of Provisio
Aurora Cannabis Announces Fiscal 2022 First Quarter EDMONTON, AB, Nov. 9, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational r
Read more →-ACB
Nov 8, 2021▲ +9.6%on this newsshared move
Aurora Cannabis Acquires a Significant Equity Stake in Growery B.V., One of 10 Successful Applicants for a Cannabis Production Licence in the Netherlands First Federally Regulated Recreational Market in Europe and Larges
Aurora Cannabis Acquires a Significant Equity Stake in Growery B.V., One of 10 Successful Applicants for a Cannabis Production Licence in the Netherlands First Federally Regulated Recreational Market in Europe and Largest Outside of Canada EDMONTON, AB, Nov. 8, 2021 /CNW/ - A
Read more →-ACB
Oct 28, 2021Aurora Announces Manufacturing Agreement with The Valens Company New Seasonal Offerings Slated for November Release EDMONTON, AB
Aurora Announces Manufacturing Agreement with New Seasonal Offerings Slated for November Release EDMONTON, AB, Oct. 28, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide,
Read more →-ACB
Oct 26, 2021Aurora Cannabis to Host First Quarter Fiscal Year 2022 Investor Conference Call EDMONTON, AB
Aurora Cannabis to Host First Quarter Fiscal Year 2022 Investor Conference Call EDMONTON, AB, Oct. 26, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today t
Read more →-ACB
Oct 6, 2021WHAT'S INSIDE: LETTER TO SHAREHOLDERS NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS SOLICITATION OF PROXIES 1 GENERAL PROXY INFORMATION 1 RECORD DATE, VOTING SECURITIES AND PRINCIPAL HOLDERS OF VOTING SECURITIES 4 DOC
WHAT'S INSIDE: LETTER TO SHAREHOLDERS NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS SOLICITATION OF PROXIES 1 GENERAL PROXY INFORMATION 1 RECORD DATE, VOTING SECURITIES AND PRINCIPAL HOLDERS OF VOTING SECURITIES 4 DOCUMENTS INCORPORATED BY REFERENCE 4 PARTICULARS OF MATTERS
Read more →-ACB
Sep 27, 2021▲ +7.3%on this news
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results NASDAQ | TSX: ACB #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin be
Aurora Cannabis Announces Fiscal 2021 Fourth EDMONTON, AB, Sept. 27, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational result
Read more →-ACB
Sep 20, 2021▼ -7.5%on this news
Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday
Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021 EDMONTON, AB, Sept. 20, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB)
Read more →-ACB
Sep 7, 2021Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings NASDAQ | TSX
Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings EDMONTON, AB, Sept. 7, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the
Read more →-ACB
Aug 25, 2021Aurora Cannabis Marks Successful Inaugural Fulfillment for French Pilot Program NASDAQ | TSX: ACB Initial fulfillment satisfies obligation as primary provider of dried medical cannabis Premium, medical cannabis products
Aurora Cannabis Marks Successful Inaugural Fulfillment for French Pilot Program Initial fulfillment satisfies obligation as primary provider of dried medical cannabis Premium, medical cannabis products sourced from the company's EU GMP facility in Denmark EDMONTON, AB, Aug.
Read more →-ACB
Jul 26, 2021Aurora Cannabis Announces Appointment of New Independent Director Distinguished senior healthcare executive, Theresa Firestone, to fill newly added position NASDAQ | TSX
Aurora Cannabis Announces Appointment of New Independent Director Distinguished senior healthcare executive, Theresa Firestone, to fill newly added position EDMONTON, AB, July 26, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Can
Read more →-ACB
Jul 15, 2021Aurora Cannabis Delivers $8 Million Shipment of Cannabis to Israel Shipment is part of the Company's strategy to advance its leadership in the global cannabinoid space NASDAQ | TSX
Aurora Cannabis Delivers $8 Million Shipment of Cannabis to Israel Shipment is part of the Company's strategy to advance its leadership in the global cannabinoid space EDMONTON, AB, July 15, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: AC
Read more →-ACB
Jun 1, 2021Aurora Cannabis Completes Balance Sheet Restructuring Full Repayment of Credit Facility Results in Principal and Interest Savings of ~$25 Million In the Next Year NASDAQ | TSX
Aurora Cannabis Completes Balance Sheet Restructuring Full Repayment of Credit Facility Results in Principal and Interest Savings of ~$25 Million In the Next Year EDMONTON, AB, June 1, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), th
Read more →-ACB
May 28, 2021Aurora Cannabis to Participate in Three Upcoming Virtual Investor Conferences NASDAQ | TSX
Aurora Cannabis to Participate in Three Upcoming Virtual Investor Conferences EDMONTON, AB, May 28, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that
Read more →-ACB
May 27, 2021New Science & Innovation Business Unit to Advance Aurora's Leadership in Biosynthesis and Plant Genetics The Company's patented technology expected to be key to commercial success in cannabinoid biosynthesis NASDAQ | TSX
New Science & Innovation Business Unit to Advance Aurora's Leadership in Biosynthesis and Plant Genetics The Company's patented technology expected to be key to commercial success in cannabinoid biosynthesis EDMONTON, AB, May 27, 2021 /CNW/ - Aurora Cannabis Inc. (NASDAQ: AC
Read more →-ACB
May 25, 2021Aurora Cannabis to Begin Trading on the The Nasdaq Global Select Market on
Aurora Cannabis to Begin Trading on the The Nasdaq Global Select Market on May 25, 2021 at Market Open EDMONTON, AB, May 24, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide,
Read more →-ACB
May 20, 2021Aurora Announces Filing of Prospectus Supplement for At-The-Market Offering Program NYSE | TSX
Aurora Announces Filing of Prospectus Supplement for At-The-Market Offering Program EDMONTON, AB, May 20, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, has filed a pros
Read more →-ACB
May 14, 2021Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference EDMONTON, AB
Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference EDMONTON, AB, May 14, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that
Read more →-ACB
May 12, 2021Aurora Cannabis Announces Fiscal 2021 Third Quarter Results Domestic Medical Net Revenue Steady at $26.9 Million Strong International Medical Net Revenue of $9.4 Million Total Cannabis Net Revenue, Excluding Provisions,
Aurora Cannabis Announces Fiscal 2021 Third Quarter EDMONTON, AB, May 13, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational res
Read more →-ACB
Apr 30, 2021Aurora Cannabis to Host Third Quarter Fiscal Year 2021 Investor Conference Call NYSE | TSX
Aurora Cannabis to Host Third Quarter Fiscal Year 2021 Investor Conference Call EDMONTON, AB, April 30, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today th
Read more →-ACB
Mar 10, 2021Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus NYSE | TSX
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus EDMONTON, AB, March 10, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced it has filed
Read more →-ACB
Feb 10, 2021Aurora Cannabis Announces Fiscal 2021 Second Quarter Results Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020 Medical Cannabis Net Revenue of $38.9 Million, Up 42% Ve
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results EDMONTON, AB, Feb. 11, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and oper
Read more →-ACB
Jan 28, 2021Aurora Cannabis to Host Second Quarter Fiscal Year 2021 Investor Conference Call NYSE | TSX
Aurora Cannabis to Host Second Quarter Fiscal Year 2021 Investor Conference Call EDMONTON, AB, Jan. 28, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ABC) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today th
Read more →-ACB
Jan 27, 2021Aurora Cannabis and MedReleaf Australia Announce Strategic Agreement Broadest Medical Cannabis Product Range in Australian Market NYSE | TSX
Aurora Cannabis and MedReleaf Australia Announce Strategic Agreement Broadest Medical Cannabis Product Range in Australian Market EDMONTON, AB, Jan. 27, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the fu
Read more →-ACB
Jan 26, 2021FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 4818 31 Street East Edmonton International Airport, Alberta T9E 0V6 Item 2 Date of Material Cha
MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 4818 31 Street East Edmonton International Airport, Alberta T9E 0V6 Item 2 Date of Material Change January 26, 2021 Item 3 News Release The Company issued a news
Read more →-ACB
Jan 26, 2021AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 6,600,000 Warrants
AURORA CANNABIS INC. COMPUTERSHARE TRUST COMPANY OF CANADA Providing for the Issue of Page ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Words Importing the Singular 6 1.3 Interpretation not Affected by Headings 6 1.4 Day not a Business Day 7 1.5 Ti
Read more →-ACB
Jan 26, 2021Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full NYSE | TSX
Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full EDMONTON, AB, Jan. 26, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worl
Read more →-ACB
Jan 22, 2021EXECUTION VERSION 12,000,000 Units Aurora Cannabis Inc.
Aurora Cannabis Inc. UNDERWRITING AGREEMENT BMO Nesbitt Burns Inc. Capital Markets Inc. Canaccord Genuity Corp. CIBC World Markets Inc. 100 King Street West, 3rd Floor Aurora Cannabis Inc., a corporation incorporated under the laws of British Columbia (the Corporation ),
Read more →-ACB
Jan 22, 2021Filed by newsfilecorp.com AURORA CANNABIS INC. as Borrower - and - THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Lenders - and - BANK OF MONTREAL as Administrative Agent - and - BANK OF MONTREAL as Lead Arrang
AURORA CANNABIS INC. THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Administrative Agent as Lead Arranger and Sole Bookrunner SECOND AMENDED AND RESTATED CREDIT AGREEMENT ARTICLE I - INTERPRETATION 1.01 Definitions 1 1.02 Accounting Principles 25 1.03 Currency Ref
Read more →-ACB
Jan 21, 2021Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing NYSE | TSX
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing EDMONTON, AB, Jan. 21, 2021 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that
Read more →-ACB
Dec 16, 2020Aurora Cannabis Announces Operational & Balance Sheet Improvements Revised Credit Facility Terms Supports Execution of Business Transformation Plan that Focuses on Long-Term, Sustainable Revenue Growth & Improving Operat
Aurora Cannabis Announces Operational & Balance Sheet Improvements Revised Credit Facility Terms Supports Execution of Business Transformation Plan that Focuses on Long-Term, Sustainable Revenue Growth & Improving Credit facility terms improved including maturity extension t
Read more →-ACB
Nov 25, 2020Aurora Cannabis Announces Israeli Medical Supply Agreement with Cantek Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada Agreement with Israeli leader Cantek provides acce
Aurora Cannabis Announces Israeli Medical Supply Agreement with Cantek Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada Agreement with Israeli leader Cantek provides access to Israel's drugstore channel Finished product is c
Read more →-ACB
Nov 16, 2020FORM 51 102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. ( Aurora or the Company ) 500 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2 Date of Material Change November 10, 11 and
MATERIAL CHANGE REPORT Aurora Cannabis Inc. ( Aurora or the Company ) 500 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 November 10, 11 and 16, 2020 The news releases with respect to the material change on November 10 and 11, 2020 were disseminated through Intrado GlobeNews
Read more →-ACB
Nov 16, 2020Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering Over-Allotment Option Exercised in Full NYSE | TSX
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering Over-Allotment Option Exercised in Full EDMONTON, AB, Nov. 16, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of ca
Read more →-ACB
Nov 16, 2020Aurora Announces Results of 2020 Annual General and Special Meeting NYSE | TSX
Aurora Announces Results of 2020 Annual General and Special Meeting EDMONTON, AB, Nov. 16, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) ( TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the vot
Read more →-ACB
Nov 11, 2020EXECUTION VERSION 20,000,000 Units Aurora Cannabis Inc.
Aurora Cannabis Inc. UNDERWRITING AGREEMENT BMO Nesbitt Burns Inc. Capital Markets Inc. CIBC World Markets Inc. c/o BMO Nesbitt Burns Inc. King Street West, 3rd Floor Ladies and Gentlemen: Aurora Cannabis Inc., a corporation incorporated under the laws of British Columbia
Read more →-ACB
Nov 9, 2020Aurora Cannabis Announces Fiscal First Quarter 2021 Results #1 Canadian Medical Position by Cannabis Net Revenue & Strong International Medical Growth Cannabis Net Revenue of $67.8 million, Adjusted Gross Margin of 48%,
Aurora Cannabis Announces Fiscal First Quarter 2021 Results #1 Canadian Medical Position by Cannabis Net Revenue & Strong International Medical Growth Cannabis Net Revenue of $67.8 million, Adjusted Gross Margin of 48%, or 52% Excluding Nordic 1 Ramp Up Costs Achieved Targe
Read more →-ACB
Oct 30, 2020Aurora Cannabis Obtains Receipt for Final Base Shelf Prospectus Reiterates Fiscal Q1 Guidance NYSE | TSX: ACB Filed Final Base Shelf Prospectus Reiterates Guidance on Previously Provided Fiscal 2021 First Quarter Financi
Aurora Cannabis Obtains Receipt for Final Base Shelf Prospectus Reiterates Fiscal Q1 Guidance Filed Final Base Shelf Prospectus Reiterates Guidance on Previously Provided Fiscal 2021 First Quarter Financial Results Expects Full Compliance With All Fiscal Q1 Financial EDMONT
Read more →-ACB
Oct 28, 2020Aurora Cannabis to Host First Quarter Fiscal Year 2021 Investor Conference Call NYSE | TSX
Aurora Cannabis to Host First Quarter Fiscal Year 2021 Investor Conference Call EDMONTON, AB, Oct. 28, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it
Read more →-ACB
Oct 27, 2020Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus and Provides Update on Balance Sheet Strength Existing At-The-Market (ATM) program now complete New Preliminary Base Shelf Prospectus Has Been Filed C
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus and Provides Update on Balance Sheet Strength Existing At-The-Market (ATM) program now complete New Preliminary Base Shelf Prospectus Has Been Filed Current Cash Position is Approximately $272 million EDMO
Read more →-ACB
Oct 1, 2020Aurora Cannabis Inc. (the "Company") NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS ___________________________________________________________________ When Thursday
OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS ___________________________________________________________________ When Thursday, November 12, 2020 at 10:00 a.m. (Mountain Time) Virtual Meeting Virtual meeting only via live webcast at https://web.lumiagm.com/242822694 .
Read more →-ACB
Sep 28, 2020Aurora Cannabis Announces Date of Annual General Meeting NYSE | TSX
Aurora Cannabis Announces Date of Annual EDMONTON, AB, Sept. 28, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it plans to file its Management Infor
Read more →-ACB
Sep 22, 2020Aurora Cannabis Announces Fiscal Fourth Quarter 2020 Results Continued Adjusted EBITDA Improvement Due to Strong Gross Margins and Reduced SG&A Debt Levels and CapEx Spend Down Substantially in Q4 2020 Provides Guidance
Aurora Cannabis Announces Fiscal Fourth Quarter 2020 Results EBITDA Improvement Due to Strong Gross Margins and Reduced SG&A CapEx Spend Down Substantially in Q4 2020 EDMONTON, AB, Sept. 22, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the
Read more →-ACB
Sep 14, 2020Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2020 Investor Conference Call and Related Year End Informational Filings NYSE | TSX
Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2020 Investor Conference Call and Related Year End Informational Filings EDMONTON, AB, Sept. 14, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the
Read more →-ACB
Sep 8, 2020Form 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2. Date of Material Change
Aurora Cannabis Inc. ("Aurora" 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 News releases announcing the material changes referred to in this report were disseminated by Aurora on September 8, 2020 and filed on SEDAR under Aurora's profile The Company announced that M
Read more →-ACB
Sep 8, 2020Aurora Cannabis Provides Business Updates and Announces New CEO Appoints Miguel Martin as Chief Executive Officer Expects Fiscal Q4 2020 Net Revenue Between $70 and $72 Million, Including $66 to $68 Million Cannabis Net
Aurora Cannabis Provides Business Updates and Announces New CEO Appoints Miguel Martin as Chief Executive Officer Expects Fiscal Q4 2020 Net Revenue Between $70 and $72 Million, Including $66 to $68 Million Cannabis Net Revenue To Record Up to $1.8 Billion in Goodwill Impair
Read more →-ACB
Sep 8, 2020Aurora Cannabis Appoints Miguel Martin as CEO NYSE | TSX
Aurora Cannabis Appoints Miguel Martin EDMONTON, AB, Sept. 8, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company " or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Miguel Martin has been appointed Chief
Read more →-ACB
Jul 6, 2020Aurora Cannabis Appoints International Consumer Packaged Goods Executive Miguel Martin as Chief Commercial Officer NYSE | TSX
Aurora Cannabis Appoints International Consumer Packaged Goods Executive Miguel Martin as Chief Commercial Officer EDMONTON, AB, July 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabino
Read more →-ACB
Jun 29, 2020Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors NYSE | TSX
Aurora Cannabis Announces Retirement of Terry Booth from Board of Directors EDMONTON, AB, June 29, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that Co
Read more →-ACB
Jun 24, 2020Alcanna Inc. Completes $27.6 Million Secondary Bought Deal Offering by Aurora Cannabis Inc.
Alcanna Inc. Completes $27.6 Million Secondary Offering by Aurora Cannabis Inc. NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES EDMONTON, Alberta, June 24, 2020 - Alcanna Inc. (the "Company") (TSX: CLIQ) and Aurora Cannabis Inc. ("Aurora
Read more →-ACB
Jun 23, 2020Aurora Cannabis Provides Key Updates on Business Transformation Plan NYSE | TSX: ACB Continues to Execute on Corporate Restructuring & Facility Rationalization Plan Aimed at Margin Improvement and Profitability Exiting F
Aurora Cannabis Provides Key Updates on Business Transformation Plan Continues to Execute on Corporate Restructuring & Facility Rationalization Plan Aimed at Margin Improvement and Profitability Exiting Fiscal Q4 2020 at an SG&A Run Rate of Approximately $42 Million Remains
Read more →-ACB
Jun 16, 2020Aurora Cannabis Announces Retirement of Co-Founder and President Steve Dobler NYSE | TSX
Aurora Cannabis Announces Retirement of Co-Founder and President Steve Dobler EDMONTON, AB, June 16, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that
Read more →-ACB
Jun 12, 2020Execution Copy] FIRST AMENDED AND RESTATED CREDIT AGREEMENT This Agreement dated
AMENDED AND RESTATED CREDIT AGREEMENT This Agreement dated September 4, 2019 AURORA CANNABIS INC. THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Administrative Agent as Lead Arranger and Sole Bookrunner For good and valuable consideration, the receipt and suffic
Read more →-ACB
Jun 3, 2020Filed by newsfilecorp.com Alcanna Inc. Announces $27.6 Million Secondary Bought Deal Offering by Aurora Cannabis Inc. /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/
Alcanna Inc. Announces $27.6 Million Secondary Bought Deal Offering by Aurora Cannabis Inc. /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES/ EDMONTON, Alberta, June 3, 2020 - Alcanna Inc. (the "Company") (TSX: CLIQ) and Aurora Cannabis Inc
Read more →-ACB
May 28, 2020FORM 51 102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Aurora Cannabis Inc. ( Aurora or the Company ) 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2 Date of Material Change
MATERIAL CHANGE REPORT Aurora Cannabis Inc. ( Aurora or the Company ) 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 A news release with respect to the material change referred to in this report was disseminated through Canada Newswire on May 28, 2020 and subsequently f
Read more →-ACB
May 20, 2020Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform N YSE | TSX: ACB All Share Transaction - Immediately Accretive to Shareholders on an Adju
Aurora Cannabis to Strategically Enter the United States with Acquisition of Reliva, LLC A Market Leading Mass Retail CBD Platform All Share Transaction - Immediately Accretive to Shareholders on an Adjusted EBITDA Basis Profitable Today, Reliva Adds Strategic Entry to the U
Read more →-ACB
May 14, 2020Aurora Cannabis Announces Fiscal Third Quarter 2020 Results & Operational Reset Update Net revenue of $78.4 million, excluding provisions of $2.9 million, an increase of 18% over prior quarter Consumer cannabis net reven
Aurora Cannabis Announces Fiscal Third Quarter 2020 Results & Operational Reset Update Net revenue of $78.4 million, excluding provisions of $2.9 million, an increase of 18% over prior quarter net revenue of $41.5 million, excluding provisions, a 24% increase over prior quart
Read more →-ACB
May 11, 2020Aurora Cannabis Confirms Share Consolidation Effective Date NYSE | TSX: ACB Common shares of the Company will begin trading on the New York Stock Exchange and the Toronto Stock Exchange on a post-consolidated basis at th
Aurora Cannabis Confirms Share Consolidation the Company will begin trading on the New York Stock Exchange and the Toronto Stock Exchange on a post-consolidated basis at the opening of trading on May 11, 2020 EDMONTON, May 8, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" o
Read more →-ACB
May 1, 2020Aurora Cannabis to Host Third Quarter 2020 Investor Conference Call NYSE | TSX
Aurora Cannabis to Host Third Quarter 2020 Investor Conference Call EDMONTON, May 1, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that it has scheduled a confer
Read more →-ACB
Apr 15, 2020EXECUTION
SALES AGREEMENT AMENDMENT Cowen and Company, LLC 599 Lexington Avenue BMO Capital Markets Corp. CIBC World Markets Corp. AltaCorp Capital Inc. Suite 3530, 66 Wellington Street West Toronto, Ontario M5K 1A1 Ladies and Gentlemen: to the sales agreement (the "Original Agree
Read more →-ACB
Apr 13, 2020Aurora Cannabis Provides Update on Initiatives to Strengthen Liquidity, Business Transformation Plan and COVID-19 Operational Response NYSE | TSX: ACB Strengthened Cash Position with Plans for Additional Flexibility Give
Aurora Cannabis Provides Update on Initiatives to Strengthen Liquidity, Business Transformation Plan and COVID-19 Operational Response Strengthened Cash Position with Plans for Additional Flexibility Given Economic Uncertainty Execution Against Business Transformation Plan C
Read more →-ACB
Apr 12, 2020AURORA CANNABIS INC. (the "Corporation") INFORMATION NOTICE - CONSOLIDATION OF SHARES TO INVESTORS: After careful consideration and pursuant to section 54(1) of the Business Corporations Act (British Columbia) (the " BCB
AURORA CANNABIS INC. INFORMATION NOTICE - CONSOLIDATION careful consideration and pursuant to section 54(1) of the Business Corporations Act (British Columbia) (the "BCBCA"), the board of directors of the Corporation (the "Board") approved on April 12, 2020 a resolution to, am
Read more →-ACB
Mar 16, 2020Aurora Cannabis Announces Share Sale by Founder Terry Booth Transaction in connection with the previously announced transition plan NYSE | TSX
Aurora Cannabis Announces Share Sale by Transaction in connection with the previously announced transition plan EDMONTON, March 16, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide,
Read more →-ACB
Feb 25, 2020Execution Copy AURORA CANNABIS INC. and ANANDIA LABORATORIES INC. ARRANGEMENT AGREEMENT Dated as of
AURORA CANNABIS INC. ANANDIA LABORATORIES INC. ARRANGEMENT AGREEMENT Dated as of July 15, 2018 Article 1 DEFINITIONS, INTERPRETATION AND SCHEDULES 2 Section 1.1 Definitions 2 Section 1.2 Interpretation Not Affected by Headings 19 Section 1.3 Number and Gender 19 Section 1
Read more →-ACB
Feb 13, 2020Aurora Cannabis Announces Second Quarter 2020 Results Net Revenue of $66.6 million, excluding provisions of $10.6 million Net Cannabis Revenue, excluding provisions, of $63.2 million, In Line With Recent Guidance Cash Co
Aurora Cannabis Announces Second Quarter Net Revenue of $66.6 million, excluding provisions Net Cannabis Revenue, excluding provisions, of $63.2 million, In Line With Recent Guidance Cash Cost to Produce Per Gram Sold of $0.88 Successful Launch of Cannabis 2.0 Products Acros
Read more →-ACB
Feb 10, 2020Aurora Cannabis to Host Second Quarter 2020 Investor Conference Call NYSE | TSX
Aurora Cannabis to Host Second Quarter 2020 Investor Conference Call EDMONTON, Feb. 10, 2020 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that it has scheduled a con
Read more →-ACB
Feb 7, 2020Aurora Cannabis Announces CEO Retirement and Succession, Board of Directors Expansion, and Business Transformation Plan Releases Preliminary Results for the Second Fiscal Quarter Ended
Aurora Cannabis Announces CEO Retirement and Succession, Board of Directors Expansion, and Business Transformation Plan Releases Preliminary Results for the Second Fiscal Quarter Ended December 31, 2019 Founder & CEO, Terry Booth, announces retirement and succession plan and
Read more →-ACB
Feb 6, 2020Aurora Cannabis Announces Appointment of Two New Independent Directors Friedmann and Detlefsen Bring Significant Experience in Consumer Products and Marketing NYSE | TSX
Cannabis Announces Appointment of Two New Independent Directors and Detlefsen Bring Significant Experience in Consumer Products and Marketing 6, 2020 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabi
Read more →-ACB
Feb 3, 2020Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility Achievement increases total production capacity available to serve international medical markets by 230% Brings Aurora's total number of EU GMP
Aurora Cannabis Receives EU GMP Certification for its Aurora River Facility Achievement increases total production capacity available to serve international medical markets by 230% Brings Aurora's total number of EU GMP certified Canadian production facilities to 3 Pharmaci
Read more →-ACB
Dec 23, 2019Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out NYSE | TSX: ACB Initial cannabis 2.0 shipments released to 10 provincial regulators; new products have also been made available for order count
Aurora Cannabis Provides Corporate Update and Confirms Cannabis 2.0 Roll Out Initial cannabis 2.0 shipments released to 10 provincial regulators; new products have also been made available for order countrywide by Aurora's registered medical patients Provides Update on Capita
Read more →-ACB
Dec 21, 2019Aurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer Mr. Battley Appointed to Board of Directors of MedReleaf Australia TSX | NYSE
Aurora Cannabis Announces Change to Executive Team: Cam Battley Steps Away From his Role as Chief Corporate Officer Mr. Battley Appointed to Board of Directors of MedReleaf Australia EDMONTON, Dec. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE TSX:
Read more →-ACB
Dec 2, 2019Aurora Cannabis Achieves Highest Cannabis Corporate Boards Ranking in 2019 Globe & Mail Board Games Report TSX | NYSE
Aurora Cannabis Achieves Highest Cannabis Corporate Boards Ranking in 2019 Globe & Mail Board Games Report EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleas
Read more →-ACB
Dec 2, 2019Aurora Receives First Approval for Medicinal Cannabis Product in Ireland TSX | NYSE
Aurora Receives First Approval for Medicinal Cannabis Product in Ireland EDMONTON, Dec. 2, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that one of the Company's
Read more →-ACB
Nov 27, 2019Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall 11,000 Square Foot Retail Destination and Global Centre for Cannabis Education, Discovery and Community Engagement TSX | NYSE
Aurora Cannabis Opens Experiential Flagship Store in North America's Largest Mall Retail Destination and Global Centre for Cannabis Education, Discovery and Community Engagement EDMONTON, Nov. 27, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian co
Read more →-ACB
Nov 20, 2019Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer Appoints Dr. Shane Morris CPO and Andr J r me CIO TSX | NYSE
Aurora Cannabis Strengthens Leadership Team Adding Chief Product Officer and Chief Integration Officer Appoints Dr. Shane Morris CPO and Andr J r me CIO EDMONTON, Nov. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE TSX: ACB), the Canadian company def
Read more →-ACB
Nov 14, 2019Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan NYSE | TSX: ACB Reports Industry Leading Gross Profit of $53.7 Million and 58% Cannabis Gross Margin Delivers Best-in-Class Indoor Cash Cost to
Aurora Cannabis Announces First Quarter 2020 Results & Corporate Action Plan Reports Industry Leading Gross Profit of $53.7 Million and 58% Cannabis Gross Margin Delivers Best-in-Class Indoor Cash Cost to Produce Announces Plan to Settle March 2020 5.0% Convertible Revises
Read more →-ACB
Nov 14, 2019Aurora Cannabis Announces Temporary Amended Early Conversion Privilege for its 2020 Convertible Debentures Secures Commitment of Investors Holding Approximately $155 million of Debentures to Covert TORONTO
Aurora Cannabis Announces Temporary Amended Early Conversion Privilege for its 2020 Convertible Debentures Secures Commitment of Investors Holding Approximately $155 million of Debentures to Covert TORONTO, Nov. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Compan
Read more →-ACB
Nov 11, 2019Aurora Cannabis Announces 2019 AGM Voting Results All Items of Business Approved EDMONTON
Aurora Cannabis Announces 2019 AGM Voting All Items of Business EDMONTON, Nov. 11, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" or the "Issuer") (NYSE TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the voting results
Read more →-ACB
Oct 16, 2019Consumer Legalization One Year Later: Aurora Cannabis Reveals Sneak Peek of Plans for NextGen Cannabis Products NYSE | TSX
Consumer Legalization One Year Later: Aurora Cannabis Reveals Sneak Peek of Plans for NextGen Cannabis Products EDMONTON, Oct. 16, 2019 /CNW/ - On the one-year anniversary of consumer legalization in Canada, Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian compa
Read more →-ACB
Oct 8, 2019Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers Dissolve Strips Now Available to Aurora's Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON
Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers Now Available to Aurora's Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct. 8, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian
Read more →-ACB
Oct 3, 2019Aurora Cannabis Provides Update on Global Operations and Growth Initiatives TSX: ACB | NYSE: ACB Cultivation Leadership Further Strengthened as Global Facilities Achieve Significant Milestones Global Market Expansion Con
Aurora Cannabis Provides Update on Global Operations and Growth Initiatives TSX: ACB | NYSE: ACB Cultivation Leadership Further Strengthened as Global Facilities Achieve Significant Milestones Global Market Expansion Continues in Medical Cannabis Network of Strategic Partne
Read more →-ACB
Sep 23, 2019NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS We are pleased to invite you to the Annual General Meeting of the Shareholders of Aurora Cannabis Inc. (the " Company "), to be held at the Renaissance Edmonton Internatio
NOTICE OF ANNUAL GENERAL MEETING OF We are pleased to invite you to the Annual General Meeting of the Shareholders of Aurora Cannabis Inc. (the "Company"), to be held at the Renaissance Edmonton International Hotel, Cartier Room, 4236 - 36 Street E., Edmonton International Air
Read more →-ACB
Sep 20, 2019Aurora Cannabis Announces Date of Annual General Meeting TSX: ACB | NYSE
Aurora Cannabis Announces Date of Annual TSX: ACB | NYSE: ACB EDMONTON, Sept. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that it will hold its Annual Gene
Read more →-ACB
Sep 20, 2019LIQUOR STORES N.A. LTD. - and - AURORA CANNABIS INC. - and - 2095173
LIQUOR STORES N.A. LTD. AURORA CANNABIS INC. 2095173 ALBERTA LTD. Article 1 DEFINITIONS AND INTERPRETATION 2 1.1 Definitions 2 1.2 Interpretation 5 1.3 Date for any Action 6 1.4 Governing Law and Attornment 6 Article 2 THE INVESTMENT 7 2.1 The Investment 7 2.2 Aurora Guarantee
Read more →-ACB
Sep 11, 2019Aurora Cannabis Announces Financial Results for the Fourth Quarter and 2019 Fiscal Year Generates Net Revenue of $98.9 Million, Up 52% From Prior Quarter Cannabis Net Revenue Increases 61% to $94.6 Million From Prior Qua
Aurora Cannabis Announces Financial Results for the Fourth Quarter and 2019 Fiscal Year Generates Net Revenue of $98.9 Million, Up 52% From Prior Quarter Cannabis Net Revenue Increases 61% to $94.6 Million From Prior Quarter Reports Gross Margin on Cannabis Net Revenue of 58
Read more →-ACB
Sep 9, 2019Aurora Cannabis Closes Expanded C$360 Million (US$280 Million) Credit Facility NYSE | TSX
Aurora Cannabis Closes Expanded C$360 Million (US$280 Million) Credit Facility EDMONTON, Sept. 9, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, is pleased to announce that it has
Read more →-ACB
Sep 4, 2019Aurora Cannabis Announces Sale of Remaining Shares in The Green Organic Dutchman Sale of Non-Core Holdings Raises Gross Proceeds of $86.5 Million NYSE | TSX
Aurora Cannabis Announces Sale of Remaining Shares in The Green Organic Dutchman Sale of Non-Core Holdings Raises Gross Proceeds of $86.5 Million EDMONTON, Sept. 4, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora or the "Company") (NYSE | TSX: ACB), the Canadian company defining
Read more →-ACB
Sep 3, 2019Aurora Cannabis to Host Fourth Quarter 2019 Investor Conference Call NYSE: ACB | TSX
Aurora Cannabis to Host Fourth Quarter 2019 Investor Conference Call NYSE: ACB | TSX: ACB EDMONTON, Sept. 3, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), today announced that it has scheduled its conference call to discuss the results for
Read more →-ACB
Aug 19, 2019Aurora Cannabis Completes Hempco Food and Fibre Acquisition NYSE | TSX : ACB Introduces Aurora Hemp: A Global Hemp Leader Focused on CBD and Organic Hemp Food Products EDMONTON
Aurora Cannabis Completes Hempco Food and Fibre Acquisition Hemp: A Global Hemp Leader Focused on CBD and Organic Hemp Food Products EDMONTON, Aug. 19, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of
Read more →-ACB
Aug 15, 2019Aurora Cannabis Announces Upsizing of Credit Facility to Approximately C$360 Million (US$280 Million) NYSE | TSX : ACB Broader Lending Syndicate Introduced to Fund Strategic Growth Initiatives EDMONTON
Aurora Cannabis Announces Upsizing of Credit Facility to Approximately C$360 Million (US$280 Million) Broader Lending Syndicate Introduced to Fund Strategic Growth Initiatives EDMONTON, Aug. 15, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora or the "Company") (NYSE | TSX: ACB),
Read more →-ACB
Aug 6, 2019Aurora Cannabis Provides Corporate Update for the Fourth Quarter of Fiscal 2019 TSX | NYSE
Aurora Cannabis Provides Corporate Update for the Fourth Quarter of Fiscal 2019 EDMONTON, Aug. 6, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today provided a corporate update
Read more →-ACB
Jul 24, 2019Aurora Cannabis and UFC Launch Clinical Research on Use of Hemp-Derived CBD Products by MMA Athletes New studies to advance the science on CBD use and athlete health and wellness and to drive product development under ne
Aurora Cannabis and UFC Launch Clinical Research on Use of Hemp-Derived CBD Products by MMA Athletes New studies to advance the science on CBD use and athlete health and wellness and to drive product development under new U.S. sports performance brand, TSX: ACB | NYSE: ACB L
Read more →-ACB
Jul 18, 2019Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender Secures Two-Year Contract to Continue to Supply Italy with high-quality medical cannabis NYSE: ACB TSX:ACB EDMONTON
Aurora Cannabis Selected as Sole Winner in Italian Cannabis Tender Contract to Continue to Supply Italy with high-quality medical cannabis EDMONTON, July 18, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian company defining th
Read more →-ACB
Jul 15, 2019Aurora Cannabis Obtains Two Licences for Outdoor Growing Operations New Outdoor research sites in Quebec and British Columbia to study best-in-class cultivation techniques and advance plant science NYSE: ACB TSX:ACB EDMO
Aurora Cannabis Obtains Two Licences for Outdoor Growing Operations New Outdoor research sites in Quebec and British Columbia to study best-in-class cultivation techniques and advance plant science EDMONTON, July 15, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Compan
Read more →-ACB
Jun 21, 2019Aurora Cannabis Prepared for Expansion of Canada's Cannabis Market Efficient distribution, new partnerships and a broad range of high-margin products to be launched in major consumer markets NYSE: ACB TSX:ACB EDMONTON
Aurora Cannabis Prepared for Expansion of Canada's Cannabis Market Efficient distribution, new partnerships and a broad range of high-margin products to be launched in major consumer markets EDMONTON, June 21, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (N
Read more →-ACB
May 21, 2019Aurora Cannabis and UFC Join Forces to Advance CBD Research, Education, and Product Development Multi-Year Global Partnership will Advance Science on Athlete Health and Wellness NYSE: ACB TSX:ACB EDMONTON
Aurora Cannabis and UFC Join Forces to Advance CBD Research, Education, and Product Development Partnership will Advance Science on Athlete Health and Wellness EDMONTON, May 21, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB), the Canadian
Read more →-ACB
May 14, 2019Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019 Solid Net Revenue Growth Across All Channels to $65.1 Million Production Volumes Double While Per-Unit Production Costs Decline On Track to
Aurora Cannabis Announces Financial Results for the Third Quarter of Fiscal 2019 Growth Across All Channels to $65.1 Million Production Volumes Double While Per-Unit Production Costs Decline On Track to Deliver Positive EBITDA Beginning in Fiscal Q4 2019 TSX: ACB | NYSE: ACB
Read more →-ACB
May 13, 2019Aurora Cannabis and Radient Technologies Announce First Commercial Delivery of Cannabis Derivatives Transformational Milestone for Radient, Increasing Aurora's Global Derivative Market Capacity Substantially TSX: ACB | N
Aurora Cannabis and Radient Technologies Announce First Commercial Delivery of Cannabis Derivatives Transformational Milestone for Radient, Increasing Aurora's Global Derivative Market Capacity Substantially TSX: ACB | NYSE: ACB, TSXV: RTI EDMONTON, May 13, 2019 /CNW/ - Auro
Read more →-ACB
May 9, 2019Aurora Cannabis Extends Exclusive Supply Relationship with Luxembourg TSX | NYSE
Aurora Cannabis Extends Exclusive Supply Relationship with Luxembourg EDMONTON, May 9, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company, through its wholly owned subsidiary Auro
Read more →-ACB
May 6, 2019Aurora Cannabis to Host Third Quarter 2019 Investor Conference Call on
Aurora Cannabis to Host Third Quarter 2019 Investor Conference Call on May 15, 2019 TSX: ACB | NYSE: ACB EDMONTON, May 6, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), today announced that it has scheduled
Read more →-ACB
Apr 26, 2019Aurora Cannabis and EnWave Corporation Enter Global Licensing Arrangements Establish Intellectual Property Partnership and $10 Million Strategic Equity Investment NYSE | TSX: ACB TSX-V: ENW EDMONTON and VANCOUVER
Aurora Cannabis and EnWave Corporation Enter Global Licensing Arrangements Establish Intellectual Property Partnership and $10 Million Strategic Equity Investment EDMONTON and VANCOUVER, April 26, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE
Read more →-ACB
Apr 25, 2019Aurora Bolsters Anandia's Testing Capabilities Through Acquisition of Chemi Pharmaceutical Supporting the Growth and Expansion of Anandia's Independent Cannabis Testing Capabilities TSX | NYSE
Aurora Bolsters Anandia's Testing Capabilities Through Acquisition of Chemi Pharmaceutical Supporting the Growth and Expansion of Anandia's Independent Cannabis Testing Capabilities EDMONTON, April 25, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB)
Read more →-ACB
Apr 18, 2019Aurora Cannabis Provides Update On German Cannabis Production Tender Public Appeal Process Completed - Facility Construction to Begin in May 2019 TSX | NYSE
Aurora Cannabis Provides Update On German Cannabis Production Tender Public Appeal Process Completed - Facility Construction to Begin in May 2019 EDMONTON, April 18, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1
Read more →-ACB
Apr 16, 2019Aurora Cannabis to Acquire Remaining Interest in Hempco Food and Fiber Inc. Strengthens Execution of Aurora's Global Hemp and CBD Strategy TSX | NYSE: ACB TSX/V
Aurora Cannabis to Acquire Remaining Interest in Hempco Food and Fiber Inc. Strengthens Execution of Aurora's Global Hemp and CBD Strategy TSX | NYSE: ACB TSX/V: EDMONTON, April 16, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1
Read more →-ACB
Apr 10, 2019Aurora Cannabis Provides Construction Update on Aurora Sun Facility Footprint Increased to 1.6 Million Square Feet, Target Capacity 230,000+ kg per Annum Next Generation Technology Systems to Result in Further Reduced Pr
Aurora Cannabis Provides Construction Update on Aurora Sun Facility Footprint Increased to 1.6 Million Square Feet, Target Capacity 230,000+ kg per Annum Next Generation Technology Systems to Result in Further Reduced Production Costs EDMONTON, April 10, 2019 /CNW/ - Aurora
Read more →-ACB
Apr 5, 2019Aurora Cannabis Awarded Maximum Number of Lots in German Cannabis Production Tender Company Submitted Best Overall Concept, Paving Way to Establish Local Production TSX | NYSE
Aurora Cannabis Awarded Maximum Number of Lots in German Cannabis Production Tender Company Submitted Best Overall Concept, Paving Way to Establish Local Production EDMONTON, April 5, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frank
Read more →-ACB
Apr 4, 2019Aurora Cannabis Expands Management Team to Support Strategic Initiatives TSX | NYSE: ACB Appoints Carey Squires as Executive Vice President, Corporate Development & Strategy EDMONTON
Aurora Cannabis Expands Management Team to Support Strategic Initiatives Appoints Carey Squires as Executive Vice President, Corporate Development & Strategy EDMONTON, April 4, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) today announc
Read more →-ACB
Apr 2, 2019Aurora Files Preliminary Base Shelf Prospectus TSX: ACB | NYSE: ACB Provides Flexibility to Execute on Aurora's Global Expansion and Partnering Strategy EDMONTON
Aurora Files Preliminary Base Shelf Prospectus TSX: ACB | NYSE: ACB Provides Flexibility to Execute on Aurora's Global Expansion and Partnering Strategy EDMONTON, April 2, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; W
Read more →-ACB
Mar 13, 2019Aurora Cannabis Appoints Nelson Peltz as Strategic Advisor NYSE| TSX: ACB EDMONTON and
Aurora Cannabis Appoints Nelson Peltz as Strategic Advisor EDMONTON and NEW YORK, March 13, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has appointed Nelson Peltz as a Strategic Adv
Read more →-ACB
Mar 11, 2019Aurora Commences Cannabis Oil Sales to German Pharmacies High-Margin Derivative Products Accelerating European Revenue Growth TSX | NYSE
Aurora Commences Cannabis Oil Sales to High-Margin Derivative Products Accelerating European Revenue Growth EDMONTON, March 11, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has comm
Read more →-ACB
Mar 7, 2019Aurora Cannabis Provides Update on its Strategic Investment in Choom TSX | NYSE
Aurora Cannabis Provides Update on its Strategic Investment in Choom EDMONTON, March 7, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today provided an update on its strategic investment in Choom Holdings In
Read more →-ACB
Mar 4, 2019Aurora Completes Whistler Medical Acquisition Adding Iconic Organic Certified Premium Cannabis Brand TSX: ACB | NYSE
Aurora Completes Whistler Medical Acquisition Adding Iconic Organic Certified Premium Cannabis Brand TSX: ACB | NYSE: ACB EDMONTON, March 4, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today tha
Read more →-ACB
Feb 26, 2019Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora's International Footprint to 24 Countries TSX |
Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora's International Footprint to 24 Countries EDMONTON, Feb. 26, 2019 /CNW/ - Aurora Cannabis Inc. (TSX: A
Read more →-ACB
Feb 25, 2019Aurora Cannabis Receives Health Canada Licensing of Aurora Sky and MedReleaf Bradford Sky and Bradford Facilities Combine for Over 128,000 kg per Year Production Capacity TSX | NYSE
Aurora Cannabis Receives Health Canada Licensing of Aurora Sky and MedReleaf Bradford Sky and Bradford Facilities Combine for Over 128,000 kg per Year Production Capacity EDMONTON, Feb. 25, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB)
Read more →-ACB
Feb 21, 2019Aurora Cannabis Broadens Senior Leadership Team TSX | NYSE: ACB Darren Karasiuk Promoted to Chief Commercial Officer and Jill Swainson Promoted to Chief Legal Officer and Corporate Secretary EDMONTON
Aurora Cannabis Broadens Senior Leadership Darren Karasiuk Promoted to Chief Commercial Officer and Jill Swainson Promoted to Chief Legal Officer and Corporate Secretary EDMONTON, Feb. 21, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (F
Read more →-ACB
Feb 20, 2019Aurora Cannabis Announces Key Changes to its Board of Directors TSX | NYSE
Aurora Cannabis Announces Key Changes to its Board of Directors EDMONTON, Feb. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that Michael Singer, previously Chairman of the Board, has bee
Read more →-ACB
Feb 13, 2019Aurora Cannabis Provides Update on its Strategic Investment in High Tide Inc. TSX | NYSE
Aurora Cannabis Provides Update on its Strategic Investment in High Tide Inc. EDMONTON, Feb. 13, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today provided an update on its strategic investment in High Tid
Read more →-ACB
Feb 12, 2019Aurora Cannabis Announces Construction of Aurora Polaris Centre of Excellence for Value-Add Products, Packaging and International Logistics TSX: ACB | NYSE
Aurora Cannabis Announces Construction Centre of Excellence for Value-Add Products, Packaging and International Logistics TSX: ACB | NYSE: ACB EDMONTON, Feb. 12, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM
Read more →-ACB
Feb 11, 2019Aurora Cannabis Makes First Commercial Export to the United Kingdom TSX: ACB | NYSE
Aurora Cannabis Makes First Commercial Export to the United Kingdom TSX: ACB | NYSE: ACB EDMONTON, Feb. 11, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has completed its first comm
Read more →-ACB
Feb 11, 2019Aurora Cannabis Announces Financial Results for the Second Quarter of Fiscal 2019 83% Sequential Net Revenue Growth to $54.2 Million TSX: ACB | NYSE
Aurora Cannabis Announces Financial Results for the Second Quarter of Fiscal 2019 83% Sequential Net Revenue Growth to $54.2 Million TSX: ACB | NYSE: ACB EDMONTON, Feb. 11, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P;
Read more →-ACB
Feb 7, 2019Aurora Cannabis Announces Confirmed Time for its Conference Call to Discuss Second Quarter 2019 Results TSX | NYSE
Aurora Cannabis Announces Confirmed Time for its Conference Call to Discuss Second Quarter 2019 Results EDMONTON, Feb. 7, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), today announced a confirmed time for i
Read more →-ACB
Feb 4, 2019Aurora Cannabis Partner Radient Technologies Receives Standard Processing License NYSE| TSX: ACB Disruptive Technology an Important Component of Aurora's Derivative Products Strategy EDMONTON
Aurora Cannabis Partner Radient Technologies Receives Standard Processing License Disruptive Technology an Important Component of Aurora's Derivative Products Strategy EDMONTON, Feb. 4, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Fra
Read more →-ACB
Jan 24, 2019AURORA CANNABIS INC. and GLAS TRUST COMPANY LLC as Trustee INDENTURE Dated as of
AURORA CANNABIS INC. GLAS TRUST COMPANY LLC 5.50% Convertible Senior Notes due 2024 P AGE ARTICLE 1 D EFINITIONS Section 1.01. Definitions 1 Section 1.02. Other Definitions 14 Section 1.03. References to Interest 15 ARTICLE 2 I SSUE , D ESCRIPTION , E XECUT
Read more →-ACB
Jan 24, 2019Aurora Cannabis Closes Offering of Convertible Senior Notes NYSE: ACB | TSX
Aurora Cannabis Closes Offering of Convertible NYSE: ACB | TSX: ACB EDMONTON, Jan. 24, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has closed its previously announced offering of 5.5
Read more →-ACB
Jan 18, 2019Aurora Cannabis Prices Offering of Convertible Senior Notes TSX: ACB | NYSE
Aurora Cannabis Prices Offering of Convertible TSX: ACB | NYSE: ACB EDMONTON, Jan. 18, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has priced its previously announced offering of co
Read more →-ACB
Jan 16, 2019Aurora Cannabis Announces Private Offering of US $250 Million Of Convertible Senior Notes Due 2024 TSX: ACB | NYSE
Aurora Cannabis Announces Private Offering of US $250 Million Of Convertible Senior Notes Due 2024 TSX: ACB | NYSE: ACB EDMONTON, Jan. 16, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that
Read more →-ACB
Jan 14, 2019Aurora to Acquire Whistler A Company with an Iconic Brand, Offering Organic Certified Cannabis and Organic Certified Cannabis Derivatives TSX: ACB | NYSE
Aurora to Acquire Whistler A Company with an Iconic Brand, Offering Organic Certified Cannabis and Organic Certified Cannabis Derivatives TSX: ACB | NYSE: ACB EDMONTON, Jan. 14, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt:
Read more →-ACB
Jan 8, 2019Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M Company Provides Production Guidance and is Tracking to Achieve Positive EBITDA in Second Calendar Quarte
Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M Company Provides Production Guidance and is Tracking to Achieve Positive EBITDA in Second Calendar Quarter 2019 EDMONTON, Jan. 8, 2019 /CNW/ - Aurora Cannabis I
Read more →-ACB
Dec 27, 2018AURORA CANNABIS INC. CODE OF BUSINESS CONDUCT AND ETHICS Purpose This Code of Business Conduct and Ethics ("Code") is intended to document the principles of conduct and ethics to be followed by the employees, officers (i
CODE OF BUSINESS CONDUCT This Code of Business Conduct and Ethics ("Code") is intended to document the principles of conduct and ethics to be followed by the employees, officers (including, without limitation, the Chief Executive Officer, Chief Financial Officer and other high
Read more →-ACB
Dec 24, 2018Annual General and Special Meeting of Aurora Cannabis Inc. (the " Company ")
Annual General and Special Meeting of Aurora Cannabis Inc. (the "Company") REPORT OF VOTING RESULTS National Instrument 51-102 - Continuous Disclosure Obligations Section 11.3 Outcome of Vote Votes For Votes Against 1. To fix the number of directors at eight. Carried 145,5
Read more →-ACB
Dec 13, 2018Aurora Cannabis Expands Retail Exposure Through Strategic Investment in High Tide Participating in a Rapidly Growing Cannabis and Lifestyle Accessories Retailer TSX | NYSE
Aurora Cannabis Expands Retail Exposure Through Strategic Investment in High Tide Participating in a Rapidly Growing Cannabis and Lifestyle Accessories Retailer EDMONTON, Dec. 13, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) (TSX: ACB) (Frankfurt
Read more →-ACB
Dec 10, 2018Aurora Cannabis to Acquire Mexico's Farmacias Magistrales S.A. First License to Import, Manufacture, Store, and Distribute Medical Cannabis Containing THC in Mexico TSX | NYSE
Aurora Cannabis to Acquire Mexico's Farmacias First License to Import, Manufacture, Store, and Distribute Medical Cannabis Containing THC in Mexico EDMONTON, Dec. 10, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1
Read more →-ACB
Dec 10, 2018FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2. Date of Material Change
MATERIAL CHANGE REPORT Item 1. Name and Address of Company Aurora Cannabis Inc. (" Aurora " or the " Company ") 500 - 10355 Jasper Avenue Edmonton, Alberta T5J 1Y6 Item 2. Date of Material Change November 14, 2018. Item 3. News Release A news release with respect to the ma
Read more →-ACB
Dec 7, 2018Aurora Cannabis to Enter Mexico Market via Exclusive Supply Arrangement with Farmacias Magistrales Farmacias is Sole Recipient of Federal License to Import, Formulate, Store and Sell Medical Cannabis Containing THC TSX |
Aurora Cannabis to Enter Mexico Market via Exclusive Supply Arrangement with Farmacias Magistrales Farmacias is Sole Recipient of Federal License to Import, Formulate, Store and Sell Medical Cannabis Containing THC EDMONTON, Dec. 7, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora
Read more →-ACB
Dec 6, 2018Aurora Increases EU Footprint with Medical Cannabis Shipment to Luxembourg Receives Import and Export licenses and Commences Shipment to Luxembourg Market TSX | NYSE
Aurora Increases EU Footprint with Medical Cannabis Shipment to Luxembourg Export licenses and Commences Shipment to Luxembourg Market EDMONTON, Dec. 6, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announce
Read more →-ACB
Dec 4, 2018Aurora Cannabis Announces 2018 AGM Voting Results All Items of Business Approved TSX | NYSE
Aurora Cannabis Announces 2018 AGM Voting All Items of Business EDMONTON, Dec. 4, 2018 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" or the "Issuer") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced the voting results from its Annual General and
Read more →-ACB
Dec 3, 2018Aurora Cannabis Announces Market Launch of Softgel Capsules TSX | NYSE
Aurora Cannabis Announces Market Launch EDMONTON, Dec. 3, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that, further to its October 17, 2018 announcement that it had received a sales license
Read more →-ACB
Nov 30, 2018AURORA CANNABIS INC. 500 - 10355 Jasper Avenue Edmonton, Alberta Canada T5J 1Y6 Tel: 1-855-279-4652 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND AVAILABILITY OF MEETING MATERIALS You are receiving thi
- 10355 Jasper Avenue Edmonton, Alberta Canada T5J 1Y6 OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND AVAILABILITY OF MEETING MATERIALS You are receiving this notification as Aurora Cannabis Inc. (the "Company") is using the notice and access procedures adopted b
Read more →-ACB
Nov 28, 2018Aurora Cannabis Completes Australis Distribution to Non-Resident Shareholders TSX | NYSE
Aurora Cannabis Completes Australis Distribution to Non-Resident Shareholders EDMONTON, Nov. 28, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the company, through a selling broker, has
Read more →-ACB
Nov 27, 2018Aurora Cannabis to Ship Medical Cannabis to the Czech Republic International Expansion Extends to 21 Countries TSX | NYSE
Aurora Cannabis to Ship Medical Cannabis to the Czech Republic International Expansion Extends to 21 Countries EDMONTON, Nov. 27, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the compa
Read more →-ACB
Nov 22, 2018Aurora Cannabis Receives Final Regulatory Approval and Completes Acquisition of ICC Labs Establishes Leadership Position and Platform for Growth in Latin American Market TSX | NYSE: ACB TSX-V
Aurora Cannabis Receives Final Regulatory Approval and Completes Acquisition of ICC Labs Establishes Leadership Position and Platform for Growth in Latin American Market EDMONTON, Nov. 22, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or "the Company") (NYSE: ACB) (TSX: ACB) (
Read more →-ACB
Nov 14, 2018Aurora Cannabis Appoints Dr. Jonathan Page as Chief Science Officer Promotes Dr. Shane Morris to SVP Product Development and Regulatory Affairs TSX/NYSE
Aurora Cannabis Appoints Dr. Jonathan Page as Chief Science Officer Promotes Dr. Shane Morris to SVP Product Development and Regulatory Affairs EDMONTON, Nov. 14, 2018 /CNW/ - Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce th
Read more →-ACB
Nov 13, 2018AURORA CANNABIS INC. Condensed Interim Consolidated Financial Statements (Unaudited) For the three months ended
Interim Consolidated Financial Statements For the three months ended September (In Canadian Dollars) Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of Comprehensive Income 2 Condensed Interim Consolidated Statements
Read more →-ACB
Nov 12, 2018Aurora Cannabis Announces Financial Results for the First Quarter of Fiscal 2019 260% Revenue Growth to $29.7 Million - Pro-Forma Revenues up 333% to $35.8 Million Strong Adult Consumer Roll-out and Continued Production
Aurora Cannabis Announces Financial Results for the First Quarter of Fiscal 2019 to $29.7 Million - Pro-Forma Revenues up 333% to $35.8 Million Strong Adult Consumer Roll-out and Continued Production Scale Up EDMONTON, Nov. 12, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or
Read more →-ACB
Nov 12, 2018Aurora Cannabis to Host First Quarter 2019 Investor Conference Call on
Aurora Cannabis to Host First Quarter 2019 Investor Conference Call on November 12, 2018 EDMONTON, Nov. 8, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), today announced that it has scheduled its conference
Read more →-ACB
Nov 5, 2018Aurora Cannabis Announces Grand Opening of Aurora Eau, a New Indoor Premium Cannabis Production Facility in Lachute, Quebec NYSE | TSX
Aurora Cannabis Announces Grand Opening of Aurora Eau, a New Indoor Premium Cannabis Production Facility in Lachute, Quebec LACHUTE, QC, Nov. 5, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM), is pleased to an
Read more →-ACB
Nov 5, 2018Aurora Cannabis Increases Cornerstone Investment in Cannabis Retailer Choom with Additional $20,000,000 Aurora secures right to increase ownership to 40% of Choom at $2.75 per common share EDMONTON and VANCOUVER
Aurora Cannabis Increases Cornerstone Investment in Cannabis Retailer Choom with Additional $20,000,000 Aurora secures right to increase ownership to 40% of Choom at $2.75 per common share EDMONTON and VANCOUVER, Nov. 5, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB
Read more →-ACB
Nov 1, 2018Aurora Cannabis Receives Lenders' Consent for Proposed Acquisition of ICC Milestone towards Completing Transaction to Establish Leadership in South American Market EDMONTON and VANCOUVER
Aurora Cannabis Receives Lenders' Consent for Proposed Acquisition of ICC Milestone towards Completing Transaction to Establish Leadership in South American Market EDMONTON and VANCOUVER, Nov. 1, 2018 /CNW/ - Aurora Cannabis Inc. (Aurora) (NYSE: ACB) (TSX: ACB) (Frankfurt: 2
Read more →-ACB
Oct 25, 2018Aurora Cannabis Receives First Cannabis Import Permit from Polish Ministry of Health First Licensed Producer Approved to Supply Medical Cannabis in Poland NYSE | TSX
Aurora Cannabis Receives First Cannabis Import Permit from Polish Ministry of Health First Licensed Producer Approved to Supply Medical Cannabis in Poland EDMONTON, Oct. 25, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P;
Read more →-ACB
Oct 18, 2018Aurora Cannabis Files Early Warning Report in Connection with TGOD Holding TSX
Aurora Cannabis Files Early Warning Report in Connection with TGOD Holding EDMONTON, Oct. 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM), announced today that it has filed an early warning report in respe
Read more →Competitive Position
How ACB ranks across every disease it competes inCompetitive Position is a premium feature
See how ACB ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial